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ABSTRACT
Ionic liquids (ILs) are organic salts that melt at or below 100°C. Interest in ILs continues
to grow due to their unique properties such as lack of measurable vapor pressure, high thermal
stability, tunability and recyclability. The first part of this dissertation explores the use of chiral
ionic liquids (CILs) for enantiomeric recognition of chiral analytes using fluorescence
spectroscopy. Chiral analyses continue to be a subject of considerable interest primarily as a
result of legislation introduced by the Food and Drug Administration. This has led to an
increased need for suitable chiral selectors and methods to verify the enantiomeric forms of
drugs. In this study, CILs derived from amino acid esters were used simultaneously as solvents
and chiral selectors for enantiomeric recognition of various fluorescent as well as nonfluorescent chiral analytes.
The second part of this dissertation focuses on the development of a new class of
fluorescent near infrared (NIR) nanoparticles from a Group of Uniform Materials Based on
Organic Salts (GUMBOS) largely comprising frozen ILs. The GUMBOS were subsequently
used to fabricate nanoGUMBOS using a reprecipitation method. The potential of the NIR
nanoGUMBOS for non-invasive imaging was evaluated by fluorescence imaging of Vero cells
incubated with nanoGUMBOS. Fluorescence imaging of diseased cells and tissues is useful for
early detection and treatment of diseases. The work presented here is significant and may
improve the quality of human life by employing NIR nanoGUMBOS as contrast agents for early
diagnosis and treatment of some diseases. Through variations in the anion, different spectral
properties were observed for nanoGUMBOS presenting the possibility of using a single dye for
multiple applications.

xvi

CHAPTER 1
INTRODUCTION
1.1. Ionic Liquids (ILs)
ILs are defined as organic salts with a melting point at or below 100 ºC.1, 2 Although ILs
received increased attention recently, they have been known since 1914 when Paul Walden
discovered ethylammonium nitrate with a melting point of 12 ºC, which is now regarded as the
first ionic liquid.3 An arbitrary temperature limit of 100 °C has been used to distinguish ILs from
inorganic molten salts which generally have high melting points.4 The low melting point of ILs
has been attributed to asymmetry of the component cations and anions leading to frustrated
crystal packing.5,
points

reported

6

The effect of cation symmetry is further illustrated by the higher melting
for

ILs

containing

symmetrical

1,3-dimethylimidazolium

and

1,3-

diethylimidazolium salts compared to the more unsymmetrical 1-ethyl-3-methylimidazolium or
1-butyl-3- methylimidazolium cations.7 It has also been reported by Holbrey et al. that crystal
polymorphism in 1-butyl-3-methylimidazolium halides inhibits crystal formation resulting in
ILs.8
One of the widely used method in the synthesis of ILs is anion metathesis between a
halide salt and the metal (or ammonium) salt of the desired anion. This results in ILs with cations
such as imidazolium, ammonium, pyridinium, and phosphonium cations. Examples

of

commonly used anions include bis (trifluoromethyl) sulfonimide, hexafluorophosphate,
tetrafluoroborate and nitrate.9 Another method that results in ILs is the acid-base neutralization
reaction followed by removal of water in vacuo. Indeed the first ionic liquid reported, ethyl
ammonium nitrate, was prepared using the acid-base neutralization reaction between ethylamine
and nitric acid.3 Various ILs containing amino acid anions and tetrabutylammonium or
tetrabutylphosphonium cations have also been prepared using the acid-base neutralization
1

reaction.10 Direct combination of a halide salt with a metal halide is another approach that
affords ILs. This approach is illustrated by the first preparation of the magnetic ionic liquid
[bmim] [FeCl4] by mixing equimolar amounts of [bmim] [Cl] and FeCl3.11 A further example of
direct combination is the synthesis of a series of transition metal based magnetic ILs by Del
Sesto and coworkers.12 It is interesting to note that in this combination type of reaction, there are
no by-products.11, 12
Interest in ILs stems from their unique properties such as negligible vapor pressure, high
thermal stability, high ionic conductivity, high solubility for various compounds (polar/nonpolar, organic/inorganic), and recyclability.9 In addition, ILs are easily tunable by careful choice
of cation or anion. The lack of measurable vapor pressure and high thermal stability of ILs has
been attributed to large cohesive energy density provided by Coulombic interactions between the
constituent ions.13 After being latent for sometime, research activity in room temperature ionic
liquids (RTILs) was renewed with the discovery of alkylpyridinium and 1,3-dialkylimidazolium
haloaluminate salts.14 In 1975, the first electrochemical study on these new liquid salts such as
[ethylpryidinium bromide]-[AlCl3] was reported.15 The Lewis acidity of these ILs could be tuned
by varying the molar ratio of the two ionic components. However, these haloaluminate ionic
liquids are extremely sensitive to hydrolysis by atmospheric moisture and require handling
strictly under anhydrous conditions. This problem was alleviated with the discovery of
imidazolium ILs containing tetrafluoroborate and hexafluorophosphate anions that do not impose
such special handling requirements.16, 17 However, it has been reported that hexafluorophosphate
ionic liquids releases HF in the presence of moisture and may not be suitable for electrochemical
applications.18 Overall, there are approximately 1018 possible combinations of various cations
and anions to generate ILs compared to only 600 molecular solvents currently used.19 Examples

2

of some cations and anions commonly used to prepare ILs are shown (Scheme 1.1).20, 21 Such ILs
are generally regarded as non-functionalized ILs.

Scheme 1.1. Representative common cations and anions used in the synthesis of ILs. (Adapted
from reference 18).
Over the last two decades, there has been tremendous interest in ILs research as reflected
by the steeper than exponential growth in the number of publications and patents (Figure 1.1).18
The ability to tailor the properties of ILs for specific applications has led to preparation of
various novel ILs generally known as task specific ionic liquids (TSILs). An example of TSILs is
chiral ionic liquids (CILs)22 and their use in spectroscopic chiral discrimination will be described
later in this dissertation.

Novel functionalized TSILs for metal extraction have also been

reported.23, 24 Other examples of TSILs include magnetic ILs11, 12 and protic ILs.25 In general, ILs

3

A.

B.

Figure 1.1. Annual growth of ionic liquid (A) publications from 1986-2009, and (B) patents
from 1986-2009. Note that data for 2009 is for part of the year upto July. (Adapted from
reference 18).

4

have found wide range of applications such as in catalysis26, organic synthesis27, separation28,
sensors29, electrochemistry30, 31 and energy storage.32 ILs have also been used as alternatives to
conventional organic solvents in organic synthesis33, solvent extractions34, thermal lensing35 and
in enzymatic reactions.36 In addition, ILs have proven to be useful in chromatography as buffers
in capillary electrophoresis (CE),37 stationary phases in gas chromatography (GC)38, 39 and high
performance liquid chromatography (HPLC).40 A review on analytical applications of ILs have
been published.41
In the past, ILs was a matter of academic curiosity but are now finding their way into industry.
Some industrial applications of ILs such as their uses in solar panels, batteries, fuel cells,
lubricants, drug delivery, catalysis, and gas chromatography have been extensively reviewed.18
Interesting novel uses are being made of the unique physical properties of ILs including sending
them to the moon. Borra et al. have proposed the deposition of metal films on an ionic liquid for
use in space telescopes.42 According to Borra and coworkers, this is possible because the non
volatile nature of ILs enables their use under the lunar vacuum conditions. In addition, handling
of ILs in space is a lot easier since they are less dense compared to the currently used mercury. 42
The future of ILs looks even brighter since an extrapolation of their potential uses extends to
almost every possible industrial application process (Figure 1.2).18 This dissertation focuses on
the use of CILs for enantiomeric recognition of chiral analytes using spectroscopy.
1.2. Chiral Ionic Liquids (CILs)
CILs are a subclass of ILs in which the cation or the anion (or both) may be chiral. During the
synthesis of the N-heterocyclic carbene complexes based on imidazolium precursors, Herrmann
and coworkers43 prepared two chiral imidazolium chloride salts as synthesis intermediates.
However, during this time, the two chiral imidazolium chloride salts were not referred to as CILs
in Hermann‟s work.43 Generally, CILs are a recent development as compared to achiral ILs. To
5

Figure 1.2. Prediction of the future commercial uses of ILs in various fields (adapted
from reference 18).

our knowledge, Howarth et al. synthesized the first example of a CIL in 1997 with a chiral
dialkylimidazolium cation, N,N-bis[(2S)-2-methylbutyl]imidazolium bromide, 1 (Scheme 1.2).22
This moisture stable imidazolium bromide salt was used as the Lewis acid catalyst in the DielsAlder reaction.22 In 1999, Seddon and coworkers reported the first synthesis of CIL containing
chiral anion, 1-butyl-3-methyl imidazolium lactate, 2 (Scheme 1.2).44 To our knowledge, CILs in
which both ions are chiral were rare until Machado and Dorta reported the first “doubly chiral”
ILs containing imidazolium cations and anions derived from camphor, tartaric acid and βpinene.45 Another example of CIL containing both chiral cation and anion, L-alanine butyl ester
lactate, 3, has been reported by the Warner group (Scheme 1.2).46 Most of the CILs that have
been explored have point (or central) chirality. We note that CILs with axial47 and planar48
chirality have also been recently synthesized.
6

Scheme 1.2. Structural examples of CILs containing chiral: cation (1), anion (2) cation and anion
(3).
Since the discovery of CILs, there have been extensive studies on their synthesis and
applications. The most commonly used methods in the synthesis of CILs are anion metathesis46
and acid-base neutralization reactions.10 Details of the synthesis and applications of various CILs
are provided in several outstanding reviews.49-55 More interestingly, CILs can be designed and
tailored to specific applications by simply changing the cation, anion or their combination. The
3

tunability of CILs is one of the unique and highly desirable properties of ILs. The applications of
CILs may be categorized into asymmetric synthesis and catalysis, enantiomeric chromatographic
separation, and chiral spectroscopic discrimination.56 Although the the focus of this dissertation
is on the use of CILs for enantiomeric recognition using nuclear magnetic resonance (NMR) and
fluorescence spectroscopy, the various applications of CILs will be discussed briefly in the
following section.
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1.2.1. Applications of Chiral Ionic Liquids
1.2.1.1. CILs in Asymmetric Catalysis and Synthesis
As noted earlier, CILs have been used for various applications. In contrast to regular organic
solvents, CILs can serve as chiral solvents and catalysts. Moreover, the relatively simple
synthesis of CILs from the readily available chiral starting materials such as amino acids and the
possibility of recycling CILs (due to their non-volatility) make them promising new chiral
solvents in asymmetric catalysis and synthesis. Thus CILs have been used as chiral solvents and
catalysts for various organic reactions such as Baylis-Hillman57, hydrogenation58, Heck
reaction59, and Michael addition.60 The application of CILs in asymmetric synthesis and catalysis
have been extensively reviewed.52, 53, 55
1.2.1.2. CILs in Enantiomeric Chromatographic Separation
The three common methods for enantiomeric separation include gas chromatography (GC),
capillary electrophoresis (CE) including micellar electrokinetic chromatography (MEKC), and
high performance liquid chromatography (HPLC). CILs can be used for chromatographic
separations due to their properties such as high thermal stability and ionic conductivity.
1.2.1.2.1. CILs in GC Separation
The low vapor pressure and high thermal stability of CILs render them suitable for
enantioseparations in gas chromatography (GC). Recently, CILs have been used as chiral
stationary phases in GC.61 Armstrong and coworkers carried out enantiomeric separation of
chiral alcohols and diols, chiral sulfoxides, some chiral epoxides and acetamides using a CIL
based on ephedrinium salt. Another example is the use of the CIL, (R)-N,N,N-trimethyl-2aminobutanol-bis(trifluoromethanesulfon) imidate as chiral selector for a variety of compounds
in GC.62
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1.2.1.2.2. CILs in CE and MEKC Separation
The conductivity of ILs offers the possibility of using them as electrolytes in CE.
Enantiomeric separation using CILs in CE is often a desirable alternative, especially when there
is a trace amount of sample available and short analysis time is required. Yuan and coworkers
found that the CIL, (R)-N,N,N-trimethyl-2-aminobutanol bis(trifluoromethylsulfonyl)imide, is a
good chiral selector that could be used in CE for enantioseparation of various compounds such as
propranolol.62 Recently, Tran and Mejac demonstrated the separation of various pharmaceutical
products

using

a

CIL,

S-[3-(chloro-2-hydroxypropyl)

trimethylammonium]

[bis(trifluoromethylsulfonyl)imide,], as co-electrolyte and chiral selector in the presence of
additives such as sodium cholate.63 The chiral buffer was also capable of enantiomeric
recognition of iburprofen. It is worth noting that no resolution was achieved when additives were
not used. Tran and Mejac suggest that the additives provide the three point interaction required
for chiral recognition.63
Two CILs [(ethyl and phenyl choline cations with bis (trifluoromethylsulfonyl) imide) anion]
have been evaluated by Francois et al. as chiral selectors for enantiomeric separation of
arylpropionic acids by CE.64 No direct enantioselectivity was observed for these two CILs,
except in the presence of β-cyclodextrins, suggesting that a synergistic effect of the two selectors
is responsible for increased resolution and separation efficiency. Tran and Mejac demonstrated
an influence of the β-cyclodextrin on the competition between the analyte and the IL cation with
respect to β-cyclodextrin complexation. However, the presence of the phenyl group in the IL
cation appeared to be less important in enhancing the synergistic effects. This indicates that
specific ion-pairing interactions could be involved.64 Maier and coworkers synthesized a new
CIL, [S-(−)-2-hydroxymethyl-1,1-dimethylpyrrolidinium tetrafluoroborate] derived from L-
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proline alcohol and found it to be an effective additive to acidic background electrolytes
affording the separation of a mixture of five achiral tricyclic antidepressants using CE.65
The application of novel IL-type surfactants and their polymers for chiral separation of
acidic analytes in MEKC was reported in 2006 by Rizvi and Shamsi.66 These were derived from
the monomers and polymers of undecenoxycarbonyl-L-leucinol bromide which is an IL at room
temperature, and undecenoxy carbonyl- L-pyrolidinol bromide, that forms a greasy solid with a
melting point of 30-35°C. Chiral separation was suggested to be strongly dependent on the
presence of opposite charge as well as the structural compatibility between the chiral selector and
the analyte.66
1.2.1.2.3. CILs in HPLC Separation
In liquid chromatography (LC), the low vapor pressure of CILs is not a crucial requirement.
However, CILs may provide the desired selectivity and solubility for enantiomeric separations.
The possibility of replacing organic solvents by ILs in LC is limited by their rather high
viscosities. In addition, the use of ILs on silica stationary phases often produces interactions
between IL cations and the anionic silanol stationary phase, which lead to peak tailing and longer
retention times. To circumvent the aforementioned problems, CILs may be used as additives or
silanol blocking agents may be used to afford enantiomeric separation.67 The CIL, (R)-N,N,Ntrimethyl-2-aminobutanol-bis (trifluoromethanesulfon) imidate, has also been used in HPLC for
enantioseparation of compounds such as alcohols, amines, and amino acids.62
1.2.1.3. Applications of Chiral Ionic Liquids in Enantiomeric Spectroscopic Discrimination
In contrast to chromatographic methods, there is no “real” separation of enantiomers
using spectroscopic techniques for chiral discrimination. Interestingly, chiral spectroscopic
techniques are very useful in chiral technology for rapid and accurate determination of the
enantiopurity of chiral compounds. In addition, spectroscopy may provide important information
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regarding the structure-property relationship and mechanism of chiral interaction and
recognition. Recently, CILs have been used as the chiral selectors in spectroscopic techniques
such as nuclear magnetic resonance (NMR), fluorescence, and near infrared (NIR). In this
dissertation, NMR and fluorescence spectroscopy were used for enantiomeric recognition
studies.
1.2.1.3.1. Chiral Discrimination Using CILs in NMR Spectroscopy
One of the most common methods employed for analyses of chiral compounds is NMR
spectroscopy.68,

69

In NMR, nuclei can be classified as isochronous or anisochronous. Where

diastereotopic protons show the same chemical shift, they are said to be equivalent or
isochronous, and where they have different chemical shifts, the protons are described as
anisochronous. Enantiomers cannot be discriminated in an achiral medium because the
resonances of enantiotopic nuclei are isochronous. However, diastereoisomers may be
distinguished as the resonances are anisochronous. As long as there is a large enough
nonequivalent chemical shift to give baseline resolution of the appropriate signals, then
integration gives a direct measure of enantiomeric composition.70
Recently, CILs have been widely used as the chiral solvating agents in NMR studies. In
these applications, CILs can be dissolved in deuterated NMR solvents and used as the chiral
solvating agent. They can form diastereomeric associates in situ with substrate enantiomers via
rapidly reversible equilibriums in competition with the bulk solvent. This method is quick and
simple to perform with no problems of kinetic resolution or sample racemization which may
occur when chiral derivatizing agents are used. Nonpolar solvents such as deuterated chloroform,
benzene, and carbon tetrachloride tend to maximize the observed anisochrony between the
diastereoisomeric complexes whereas the more polar solvents such as deuterated acetonitrile,
dimethyl sulfoxide may solvate the solute and decrease peak splitting.70
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Most chiral discrimination studies of CILs in NMR have been carried out using Mosher‟s
acid (α-methoxy-α-(trifluoromethyl)phenylacetic acid).71 Mosher‟s acid was first introduced as a
chiral derivatizing agent by Mosher in 1969.71, 72 The absence of α-hydrogen in the carboxylic
group of Mosher‟s acid alleviates the problem of racemization during the derivatization. It is
now commercially available in enantiopure form, either as the acid or acid chloride. In addition,
both the 1H NMR and 19F NMR can be employed to investigate the diastereomeric interactions
since Mosher‟s acid contains both hydrogen and fluorine nuclei. The enantiomeric recognition of
the CILs described in this dissertation was investigated using Mosher‟s sodium salt.
To our knowledge, the first example of 19F NMR investigation of CILs was reported in
2002 by Wasserscheid and co-workers using chiral cations derived directly from the chiral
pool.73 The diastereomeric interactions between a racemic mixture of sodium Mosher‟s salt as
substrate and the ephedrine-based CIL, as the chiral selector was investigated using
spectroscopy. The splitting of the racemic Mosher‟s salt signal using

19

19

F NMR

F NMR clearly indicates

diastereomeric interactions between Mosher‟s salt and the CIL (Figure 1.3).73

Figure 1.3. 19F NMR of racemic sodium Mosher‟s salt in presence of ephredrinium CIL.
(Adapted from reference 73).
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The extent of peak splitting can be assigned to the strength of the diastereomeric
interactions. In other words, under identical experimental conditions, the greater splitting
indicates stronger chiral discrimination abilities of the CILs used as chiral selectors. It is also
noteworthy that the chemical shift difference for the two diastereomeric CF3-groups largely
depends on the concentration of the CILs in the deuterated solvent. Generally, the higher the
concentration of CIL, the greater the splitting of of the CF3 signal in 19F NMR. It has also been
demonstrated that the addition of water to the chiral ionic liquid solution may increase the extent
of signal splitting.73
We note that the increase in the extent of peak splitting in presence of added water is
dependent on the analyte used. For instance, Guillemin and coworkers while investigating
enantiomeric discrimination using valine based CILs found that addition of water to the NMR
solvent diminished the chemical shift difference.74 This is contradictory to the previous findings
by Wasserscheid in which the addition of water was found to significantly increase the extent of
splitting of the CF3 signals.73 The decreased chemical shift difference was attributed to breaking
of hydrogen bonds responsible for diastereomeric interaction by the water molecules. These
findings suggest that water plays different roles in chiral discrimination depending on the chiral
interaction mechanism between the CILs and the chiral analytes.
After the pioneering work by Wasserscheid, a wide variety of CILs have been investigated for
their chiral recognition ability using

19

F NMR. Examples of these CILs include chiral

thiazolinium75, carbohydrate76, spiro imidazolium77, planar cyclophane imidazolium78, amino
acids79, amino acid esters46, phenylethylamines80, and spiral borates.81
1.2.1.3.2. Chiral Discrimination Using CILs in Fluorescence Spectroscopy
Fluorescence is a spectroscopic technique which has been widely used to study molecular
interactions such as in biological systems.82 It is also a useful tool for the study of chiral
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interaction and discrimination. It can provide useful information about molecular interactions
with high sensitivity. The application of fluorescence to specifically study enantioselective
interactions and chiral recognition has been reported.83-85 Most of these fluorescence studies
involve the measurements of fluorescence emission intensities, spectral shifts and quenching
effects.
Steady state fluorescence spectroscopy has been successfully employed for enantiomeric
discrimination of chiral molecules of pharmaceutical products. The emission spectral properties
of enantiomers of a chiral molecule are identical in a non-chiral environment. In contrast,
enantiomers of chiral molecules have significantly different spectral properties in a chiral
environment as a result of induced diastereomeric complex formation with chiral selectors.
Differences in the spectral properties of enantiomers in a chiral environment therefore permit the
use of fluorescence spectroscopy for effective chiral discrimination of enantiomers. For instance,
Tran et al. used steady state fluorescence spectroscopy and partial least squares regression
analysis to accurately predict the enantiomeric excess of independent samples of propranolol,
naproxen, and warfarin.86 We note that differences in fluorescence lifetime of enantiomers in
presence of a CIL have also been used as a measure of chiral discrimination.87 In this
dissertation, steady state has been used for enantiomeric discrimination of various fluorescent
and non-fluorescent chiral analytes using amino acid based CILs.
1.2.1.3.3. Chiral Discrimination Using CILs in Near Infrared (NIR) Spectroscopy
The use of NIR for chiral discrimination is particularly appealing due to fast analysis time
and inexpensive instrumentation. In addition, almost all organic molecules and most inorganic
molecules are known to have NIR absorption of C-H, O-H, N-H or C=O overtone and
combination transition. This makes the non-destructive NIR spectroscopy a potentially universal
technique for chiral discrimination of guest-host complexes. An example of the practical utility
14

of near infrared (NIR) spectroscopy for chiral discrimination has been demonstrated by Tran and
coworkers

using

S-[(3-chloro-2-hydroxypropyl)

trimethylammonium]

[bis((tri-

fluoromethyl)sulfonyl)amide] CIL.88 As noted with NMR and fluorescence spectroscopy, the
diastereomeric complexes formed by the interaction between the chiral selector and chiral
analyte leads to different NIR spectra. Using regressional analysis, the enantiomeric composition
of chiral analytes such as atenolol could be accurately and sensitively determined.88
1.3. Chirality and Its Significance
Chiral analyses continues to be a subject of great interest because it has been established that
enantiomers of a chiral racemic drug may display different properties.89 Enantiomers are
stereoisomers that are non-superimposable mirror images of each other.90 It is well established
that enantiomers of a chiral molecule have the same physical and chemical properties in an
achiral medium, but different properties in a chiral environment.90 Based on this differential
interaction with chiral drugs, one enantiomer of a chiral drug may have the desired medicinal
properties while the other enantiomer may be harmful.89, 91 Examples of the effects of different
enantiomeric forms of drugs is provided (Table 1.1).91 The effect of different enantiomeric forms
of drugs was witnessed in the 1960s for thalidomide which as administered as a racemate at the
time. The incident is sometimes referred to as “thalidomide tragedy” due to the teratogenic
effects (birth defects) caused by the S-enantiomer despite the potency of the R-enantiomer in the
treatment of morning sickness in expectant women.92-94
Due to different effects caused by different enantiomers, the FDA has issued a mandate
that requires verification of the enantiomeric form of the drug.95 This has led to a new trend
called “racemic switch” implying that even drugs previously approved as racemates are being
sold as single enantiomers.95 As a result of the policy requirements, the pharmaceutical industry
are striving to produce and market enantiomerically pure drugs.96,
15

97

Thus there is a need to

develop various chiral selectors and suitable analytical methods to distinguish enantiomers. An
effort towards meeting this goal is the subject of part of this dissertation.
Table 1.1. Effects of enantiomeric and racemic forms of various drugs (adapted from reference
91).
Drug
Albuterol

Uses

Effect of enatiomeric or racemic form
of drug

Bronchodilator

- L- form therapeutic

Citalopram

Antidepressant

- Racemate cause irregular heartbeat
-R- enantiomer ineffective

Fluoxetine

Prevents migraines

- S- enantiomer potent

Ritalin
Thalidomide

- Racemate has no effect
Treat
attention
deficit -D- enantiomer is 13 times more potent
disorder in children
than L- enantiomer
Antiemetic to treat morning -S- enantiomer is teratogenic (causes
sickness in expectant women Birth defects)

Consequently, various chiral selectors such as cyclodextrins98, antibiotics99, molecular
micelles100, and crown ethers101 have been widely used because of their chiral recognition
abilities. However, the use of many current chiral selectors is often limited due to low
solubility, difficult organic syntheses, instability at high temperature, as well as high cost. In
addition, many currently available chiral selectors require the use of another solvent and
sometimes more than one solvent system if the analyte and the chiral selector are not soluble
in the same solvent. Therefore, there is a need for the development of new chiral selectors that
can be used simultaneously as solvent and chiral selector. CILs meet this requirement and
have been explored as alternative chiral selectors as noted earlier.
In this dissertation, CILs derived from amino acid esters have been synthesized and used
for enantiomeric recognition of various chiral analytes. The choice of amino acid esters is
based on their inherent chirality thus no chiral induction is required in preparation of the
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corresponding CILs. In addition, anion exchange from the commercially available amino acid
ester chlorides affords CILs in a single step. Furthermore, amino acid esters have been shown
to afford low melting point CILs compared to the amino acid counterparts due to reduced
hydrogen bonding.102 The intrinsic fluorescence of some amino acids enables the preparation
of fluorescent CILs for the enantiomeric recognition of analytes with reduced fluorescence
emission. This dissertation explores the use of both fluorescent and non-fluorescent CILs for
enantiomeric recognition of fluorescent and non-fluorescent analytes.
Spectroscopic techniques including NMR and fluorescence spectroscopy were used for
enantiomeric recognition studies of various chiral analytes in presence of CILs. UV-vis was
used to determine the absorbance and absorption wavelength maxima of the samples before
fluorescence analysis. CD was used to investigate the chiral integrity of the synthesized CILs.
These spectroscopic techniques are discussed briefly in the following section.
1.4. Spectroscopic Techniques
1.4.1. UV-Vis Absorption Spectroscopy
UV-vis absorption is molecular characterization technique used for analysis of molecules that
absorb ultraviolet and visible light. A schematic of a UV-vis absorption spectrophotometer is
shown (Figure 1.4).103 The light source produces radiant energy that passes through a
monochromator which selects the desired wavelengths. The beam splitter results in two beams of
light through the sample and the reference cells respectively. The two light outputs
(transmittances) are amplified and their ratios (or log of ratios) are electronically amplified
giving a measure of absorbance. The absorbance is proportional to concentration according to
Beer‟s law equation; A = εbc, where A is the absorbance, ε is molar absorptivity, b is sample
path length and C is the concentration.
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Figure 1.4. Schematic representation of a UV-vis spectrophotometer.
1.4.2. Circular Dichroism Spectroscopy
Circular dichroism (CD) is an optical technique used to determine the optical
configuration of chiral molecules. Enantiomers of a chiral molecule have opposite CD bands
indicating rotation of circularly polarized light in opposite directions. CD technique was used to
confirm retention of chiral configuration of the synthesized CILs. A schematic of a CD
instrument is shown (Figure 1.5).104

Figure 1.5. Schematic representation of a CD spectropolarimeter. (M, monochromator; P,
polarizer; E, electrooptic modulator; S1, sample cell; S2, reference cell; D, photomultiplier; R,
mirror.
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The light from the source passes through a monochromator which selects the desired
wavelengths. The circularly polarized light is absorbed on the basis of chirality of the molecules
in the sample. The transmitted light is elliptically polarized hence the term ellipticity used to
describe CD measurements. A second photomultiplier detector is necessary when difference CD
is required. This is achieved by reflecting the light from the sample through the reference using a
mirror into the second detector.
1.4.3. Fluorescence Spectroscopy
In this study, fluorescence spectroscopy was used for enantiomeric recognition studies of
various chiral analytes. In addition, it was used to investigate the spectral properties of
fluorescent GUMBOS and nanoGUMBOS. Fluorescence is the radiative transition between
states of the same multiplicity. The processes involved in molecular fluorescence is illustrated by
the Jablonski diagram (Figure 1.6).105, 106
Light absorption (A) from the ground state to the higher electronic states takes place on
the order of femtoseconds (10-15s). According to the Franck Condon principle, we can assume
that no nuclear displacement occurs in such a short time and therefore all transitions are vertical.
The absorbed light undergoes internal conversion (IC) to the lowest vibrational level of S 1, a fast
relaxation process that occurs on the order of picoseconds (10-12s). This is followed by
fluorescence within about 10-8s as the photon returns to the ground state. Since the energy of
emission is lower than that of absorption, fluorescence occurs at a longer wavelength (Stokes
shift). The emission spectrum is a mirror image of absorption spectrum (Franck Condon
principle). In the excited S1 state, molecules can undergo spin conversion to the first triplet state
(T1). This process is called intersystem crossing (ISC) and occurs at a longer wavelength than
fluorescence. Heavy atoms such as bromine and iodine tend to enhance phosphorescence by
facilitating ISC.
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Light from the source (mostly xenon lamp) passes through the monochromators to select
excitation and emission wavelengths. The gratings in the monochromators decrease stray light.
The emitted light from the sample monchromator is at 90° configuration to the excitation light
(Figure 1.7). This is to minimize the intense excitation light from reaching the detector which
would otherwise lead to poor detection of the relatively less intense fluorescence signal. The
light through the sample is detected usually with a photomultiplier tube and quantified with
electronic devices, presented in graphical form and stored in computers.

A = photon absorption
F= fluorescence emission
IC= internal conversion
ISC= intersystem crossing
P= phosphorescence
T1= triplet state

S2
IC
S1

ISC
T
1

A
S0

F

P

2
1
0

Figure 1.6. Jablonski diagram.
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Figure 1.7. Schematic representation of a fluorometer.
1.5. Ionic Liquids and Nanotechnology
ILs have been traditionally sought for use as solvents in various reactions. Interestingly,
although ILs are defined as organic salts with melting point at or below 100°C, there has been
little attention paid to ILs that exist in the solid state above room temperature. This is evidenced
by disappointment expressed by various researchers in the field of ILs whenever they obtain
solid products in their quest for RTILs. The pursuit for RTILs has actually led to investigations
such as using compressed CO2 to depress the melting point of frozen ILs.107 Such an example
emphasizes that the focus on ILs research is mainly on the RTILs as further exemplified by the
following excerpt from the article by Scurto and coworkers, “Often useful functional groups
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yield solid salts. A methodology or process to increase the range of ionic compounds for use as
solvents would be highly useful.”107 Another example in which obtaining solid ILs was regarded
as unfortunate since RTILs was desired is in the synthesis of amino acid CILs as solvents for
asymmetric synthesis by Bao and coworkers.108 Further examples in which the desired solvent
properties of RTILs sometimes proved elusive precluding the application of TSILS include their
uses in metal extraction23 and enantioselective synthesis.73
To our knowledge, the Warner group set the first precedence that would possibly open an
opportunity for frozen ILs by preparing novel nanomaterials.109 Such IL nanomaterials are
expected to have properties of ILs. In addition, they can be tailored to produce nanomaterials
with properties that meet specific tasks by careful choice of the cation and the anion. Even more
interestingly, the high melting point of the salts is no longer a limitation, and therefore more
applications for these nanomaterials may be realized. This idea also comes in the wake of
tremendous interest in ILs over the last two decades as reflected by the steeper than exponential
growth in the number of publications and patents as shown earlier (Figure 1.1).18 Interestingly,
the number of publications and patents in the field of nanotechnology also increased steadily in a
fashion somewhat similar to that of ILs over the last decade.110,

111

The steady increase in

nanotechnology papers and patents is illustrated in Figure 1.8.111 It is with the consideration of
unique and interesting properties of ILs and nanomaterials that our research efforts focused on
preparation of nanomaterials from ILs. Consequently these materials have been termed Group of
Uniform Materials Based on Organic salts (GUMBOS). In this dissertation, we explore the
synthesis of near infrared (NIR) fluorescent GUMBOS and nanoGUMBOS for potential
biomedical imaging applications.
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A

B

Figure 1.8. Annual growth of nanoparticle research (A) publications, and (B) patents from 19902009. Note that data for 2009 is for part of the year, only upto July. (Adapted from reference
111).
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1.5.1. NIR Fluorescent GUMBOS and NanoGUMBOS for Biomedical Imaging
1.5.2. Significance of NIR Spectral Region as a Diagnostic Window
Dyes that emit light in the NIR region have potential applications in areas such as
analytical and sensor development112, laser dyes113, organic light-emitting diodes (OLEDs)114,
invisible printing inks115, probes for photodynamic therapy116, and contrast agents for biomedical
imaging.117-119 In addition, NIR fluorescent nanoparticles are of considerable interest for in vivo
imaging because of the low absorption coefficient of human skin tissue in the long NIR
wavelength region (700-1100 nm) (Figure 1.9).120-122 This results in a high signal to noise ratio
due to minimum autofluorescence from tissues. Since light scattering is inversely proportional to
the fourth power of wavelength, there is less scattering in the long NIR wavelength region. 123
Generally, NIR optical imaging is biologically safe and tissue depths of up to 12 cm have been
successfully visualized.122

(b)

Figure 1.9. (a) Absorption coefficient of human skin tissue as a function of wavelength (Adapted
from reference 120), and (b) Absorption extinction coefficient (on a log scale) as a function of
wavelength for deoxyhaemoglobin (Hb) and oxyhaemoglobin (HbO2). (Adapted from reference
121).
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1.5.3. NIR Fluorophores for in vivo Imaging
Ideally, in vivo imaging requires NIR dyes with strong absorbance and fluorescence
emission in the NIR spectral range, photostable, as well as devoid of phototoxic effects. 121, 124 In
addition, the NIR dyes should be safe and easily cleared from the body.121,

124

In reality,

obtaining such NIR dye that meets all the requirements is a challenge. Several materials have
been explored for their emission properties in the NIR region including quantum dots125-127,
single walled carbon nanotubes128-130, lanthanides131, fluorescent proteins132, fluorophore
conjugated polymers133, gold nanoshells134, and organic dyes.135, 136 However, there are safety
concerns on the use of most of these materials. For instance, despite their high
photoluminescence efficiency, the microbial toxicity of quantum dots is well documented.137
Single walled carbon nanotubes are also useful for photothermal cancer therapy130; however, the
nanotubes have proven to significantly retard embryo development in zebrafish raising safety
concerns.138 Due to these safety concerns, indocyanine green (ICG) is currently the only NIR
organic dye approved by the FDA for use in humans.136, 139, 140 The low toxicity of ICG (LD50 of
50-80 mg/kg) has made it useful for bioimaging such as in coronary angiography141, evaluation
of hepatic function142 and monitoring blood flow.143 Table 1.2 provides a summary of the merits
and limitations of some of the aforementioned NIR emitting materials.
Clearly, there is a limited number of NIR emitting materials for biomedical applications.
In addition, ICG that is clinically proven as a contrast agent has some drawbacks such as low
fluorescence quantum yield144, poor hydrostability145 and protein binding.146 This suggests that
there is need to explore new NIR fluorescent materials for biomedical imaging applications.This
dissertation describes our research efforts towards preparation of new class of NIR fluorescent
materials we refer to as GUMBOS (Group of Uniform Materials Based on Organic Salts) for
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biomedical imaging. The GUMBOS were subsequently used to make nanoGUMBOS for
biomedical imaging applications.
The use of contrast agents for early detection of diseased tissues such as tumors is
advantageous for early disease treatment.147 For instance, NIR contrast agents have been used for
non-invasive imaging of the lymphatic system to evaluate drainage in cancerous patients. 148 This
is possible because tumors generally tend to be more permeable to the contrast agents due to
enhanced permeability and retention effect (EPR) attributed to poor lymphatic drainage by
cancerous cells.149,

150

The EPR phenomenon is illustrated in Figure 1.10.150 The use of

nanoparticles as contrast agents is particularly attractive because their small size (defined as 1100 nm)150 permits them to escape renal filtration and accumulate in the leaky tumor cells.150, 151
In addition, various studies have shown that fluorescent nanoparticles may exhibit amplified
signal as well as prolonged in vivo stability.152-155
Most contrast agents used for bioimaging are encapsulated in some form of delivery
agent such as silica or polymeric nanoparticles.153, 156 Such nanoparticle systems have suffered
from dye leakage or encapsulation inefficiencies.153, 156 In an effort to alleviate these problems,
we explore the fabrication of NIR fluorescent nanoGUMBOS without doping or encapsulating
the dye. In addition, the GUMBOS are expected to enjoy the properties of frozen ILs such as
negligible vapor pressure and the capability of tuning the properties by judicial choice of cation
and anion. The GUMBOS were prepared via anion exchange of the fluorescent NIR halide with
various anions. The nanoGUMBOS were synthesized using a simple, additive free
reprecipitation method and their bioimaging potential was explored by Vero cell labeling and
imaging using fluorescent microscopy. The synthesis, characterization and biomedical imaging
potential of these new NIR nanoGUMBOS are discussed in the following sections.
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Table 1.2. Advantages and disadvantages of common NIR fluorophores

NIR fluorophore

Organic dyes

Advantages

Disadvantages

-Safety:
IndoCyanine
Green -Poor photostability
(ICG), an organic dye is the only
NIR dye approved by FDA for -Poor hydrostability
use in humans
-Low quantum yield in aqueous
-Have desired photophysical medium
properties in the NIR spectral
region
-Photostable

Quantum dots

-Have high luminescence
efficiency

-Low molar absorptivity and
quantum yield in NIR spectral
region
-Absorption
dependent

and

emission

size

-Laser excitation damage biological
samples
-Limited functionalization

Fluorescent proteins

Useful for live cell fluorescence
imaging

-Toxic
-Limited colors available
-Prone to photobleaching
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Tumor cells

Nanoparticles

Bloodstream
Figure 1.10. Nanoparticles exit blood vessels in the tumor owing to the enhanced permeability
and retention (EPR) effect. (Adapted from reference 150).

1.5.4. Synthesis of NanoGUMBOS
In general, there are several methods used to prepare nanoparticles such as aerosol preparation,
sol-gel process, microemulsions templates and reprecipitation methods. In this dissertation, the
nanoGUMBOS were fabricated using simple, additive free reprecipitation method by dispersing
the nanoGUMBOS in water at room temperature.
1.5.4.1. Reprecipitation Method for the Synthesis of NIR NanoGUMBOS
The reprecipitation method being simple and additive free has been employed for the
preparation of various organic nanoparticles.157-160 In the reprecipitation method used in this
study, the target compound is first dissolved in an organic solvent (such as alcohols, acetonitrile
or acetone) to obtain a millimolar (mM) concentration range. This is followed by rapid injection
of a few microlitres of the solution into a vigorously stirred (or sonicated) poor solvent (water is
commonly used) at constant temperature (usually room temperature). Reprecipitation of the
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target compound takes place in the poor solvent affording nanoparticles dispersed in the
dispersion medium. An example of the reprecipitation process for the synthesis of NIR
nanoGUMBOS described in this dissertation work is depicted in scheme 1.3.
We note that hydrocarbon solvents (such as hexane, heptane, and iso-octane) may be
used as poor sovents for nanoparticle fabrication of water soluble compounds. The only
requirement is that the target compound should be soluble in corresponding hydrocarbon
miscible solvents such as acetone. It is also interesting that the nanoparticle dispersion has the
same color as the dissolved stock solution. There are factors that affect the shape, size and
spectral properties of reprecipitated nanoparticles such as the concentration of the injected
solution, temperature of the poor solvent, aging time and additives in the poor solvent (such as
surfactants).157-160

Scheme 1.3. Scheme of reprecipitation process of nanoGUMBOS fabrication showing (A) 1 mM
stock solution of NIR GUMBOS solution in ethanol, (B) injection of 100 µL of the NIR
GUMBOS solution into 5 mL of deionized water while stirring or sonicating the mixture at room
temperature, and (C) reprecipitation of NIR GUMBOS to afford NIR nanoGUMBOS dispersed
in water.
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1.6. Characterization of NanoGUMBOS
The size and size distribution of the resultant nanoparticle suspension was determined using
dynamic light scattering (DLS). The shape and size of the nanoGUMBOS was further confirmed
using electron microscopy such as transmission electron microscopy (TEM). In addition, the
aforementioned UV-vis and fluorescence spectroscopy was used to analyze the spectral
properties of the nanoGUMBOS. The use of nanoGUMBOS for biomedical imaging was
evaluated by cellular labeling studies using Vero cells and an epifluorescent microscope was
used for cell imaging. These instrumental techniques are discussed briefly in the following
section.
1.6.1. Dynamic Light Scattering (DLS)
DLS is among the techniques used for particle size determination based on the scattering of laser
light. Other light scattering methods include static light scattering (SLS), photon correlation
spectroscopy (PCS) and quasi-elastic light scattering (QELS). DLS was used to determine the
size of particles investigated in this dissertation. In DLS, light scattered from nanoparticle
surface in all directions is recorded as a function of time.161 This is in contrast to SLS in which
the scattered light is colleted as a function of direction. The Brownian motion of particles is
correlated to the fluctuations in intensity of scattered light.161 The diffusion coefficient is
obtained from this relationship enabling the determination of the particle size from the StokesEinstein equation:
r = kBT/6πηD
Where r is the radius in m; kB Boltzmann constant (1.380 × 10
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J. K-1; T is the temperature in

kelvins; η is the viscosity in pascals per second (or centipoles); D is the diffusion coefficient in
m2s-1.
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1.6.2. Transmission Electron Microscopy (TEM)
TEM is an electron probe technique in which a beam of electrons is transmitted through
the specimen resulting in formation of an image due to the interaction of electrons with the
sample.161 The specimen needs to be a few nanometers (~ 100 nm) in thickness (i.e. ultrathin) in
order to be transparent to the electron beam. In addition, the electron beam is operated in a
vacuum (achieved using pumps) to avoid the deflection of the lighter electrons by the relatively
heavier gas molecules.161 A schematic representation of a TEM microscope is shown in Figure
1.11.

Figure 1.11. Schematic representation of TEM microscope.
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The electron gun produces a stream of electrons accelerated at high voltage (100-400kV).
The electrons are accelerated by an anode through an aperture via the condenser lens which
focuses the electrons onto the sample. The sample is usually dropcasted onto a copper coated
carbon grid (100 µm thick, 3 mm diameter). The electrons transmitted through the sample passes
through another aperture onto an objective lens and are projected for viewing onto the phosphor
fluorescent screen by the projector lens. The CCD camera captures the “shadow” of the image
based on the density of the sample components.161
The advantages of using TEM imaging include high resolution (in the range of 0.05 nm)
and the capability to image any type of sample including conductors, semiconductors and
insulators.161 However, TEM has some limitations such as extensive sample preparation which is
time consuming, limited number of samples that can be imaged, small field of view, change in
structure and morphology of the sample due to high electron energy which also leads to damage
of biological samples. In addition, the requirement of vacuum conditions increases the cost of
TEM operation and maintenance.
1.6.3. Fluorescence Microscopy
Fluorescence imaging is widely used in both medicine and biological sciences. To our
knowledge, the use of fluorescence imaging in the field of medicine was first reported in 1924. It
was observed that the endogenous porphyrins exhibited autofluorescence in tumors when
irradiated with ultraviolet light.162 Since then, fluorescence has evolved into a highly developed
imaging system with the use of fluorescein163 and NIR fluorophores118 to image brain tumors.
NIR fluorophores have since gained more popularity due to the aforementioned advantages such
as better light penetration and minimum autofluorescence in the NIR wavelength range. In this
dissertation, cellular uptake of the NIR nanoGUMBOS by Vero cells was monitored using an
epifluorescent microscope.
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In principle, fluorescence microscopy involves irradiation of the sample with the
appropriate band of wavelengths, and detection of the emitted light. In an epifluorescent
microscope which was used for this study, the excitation and observed fluorescence is from
above (epi-) the sample. A diagram illustrating an epifluorescent microscope is shown below
(Figure 1.12).

Figure 1.12. Schematic diagram of an epifluorescent microscope.
As depicted in Figure 1.12 above, the excitation light from the lamp source passes
through an excitation filter where desired wavelengths are selected. The selected wavelengths
reach the dichroic mirror tilted at 45-degree angle which reflect the light at a right angle through
the objective onto the sample. In this study, the sample represents the Vero cells labeled with
NIR fluorescent nanoGUMBOS. The fluorescence emission from the irradiated sample is
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collected by the objective forming a fluorescent image. Since the emitted light is of longer
wavelengths than excitation light (due to the aforementioned Stokes shift), it can pass the
dichroic mirror through the emission filter onto the detector (CCD camera was used to capture
the images in this study). We note that a Zeiss Axiovert epifluorescent microscope used in this
study incorporates the light source, the excitation filter, dichromatic mirror, and emission filter
into an optical block referred to as a cube.
1.7. Fluorescent NIR Aggregates
The NIR nanoGUMBOS described in this dissertation displayed spectral properties that
were strikingly different from that of the corresponding GUMBOS dilute solution. Such spectral
differences have been associated with and may be due to formation of molecular dye aggregates.
This observation prompted our investigation of the type of aggregation that may be exhibited by
the NIR fluorescent nanoGUMBOS. Current extensive research in molecular dye aggregation is
stimulated by their uses in various fields such as light harvesting systems164-167, photovoltaics166,
and light emitting diodes.166
There are two types of molecular dye aggregates namely, J and H-aggregates. The Jaggregates (also known as Scheibe aggregates) were discovered independently in 1936 by
Jelly168 and Scheibe.169 In this pioneering work, a high concentration of a pseudoisocyanine
(PIC) dye depicted in Scheme 1.4 exhibited a narrow red shifted absorption band compared to
the monomer.168, 169 In addition, the fluorescence emission had narrow band and small Stokes
shift. Initially Scheibe postulated that this was due to reversible polymerization of
chromophores.169 This observation is now ascribed to strong coupling between transition dipole
moments of the molecules resulting in excitonic states upon optical excitation.170, 171
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Scheme 1.4. Pseudoisocyanine chloride (PIC).

Since their inception, considerable attention has been paid to molecular dye aggregates
due to the aforementioned potential applications. In addition, the possibility of both H and J
aggregates exhibiting superradiance, a phenomena resulting from cooperative emission has
sparked tremendous interest in studies of molecular self assemblies.172,

173

Conceptually, the

molecules are arranged in a “brickwork” manner in J-aggregates whereas in H-aggregates, the
molecules exhibit “card-pack” arrangement (Figure 1.13).174

B

Figure 1.13. Representation of molecular arrangements in aggregates showing (A) “brickwork”
arrangement in J aggregates and (B) “card-pack” arrangement in H-aggregates).

An energy level diagram has been proposed by several groups to explain the dye aggregation
phenomenon.175-177 In general, the type of aggregate formed is determined by the type of
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transitions from the excitonic interactions between electronically coupled chromophores. Large
hypsochromic shift in absorption typical for dye H-aggregates is attributed to transition dipole
interactions between two or more chromophores (H-aggregates) arranged parallel to each other
with a small dislocation (Fig. 1.14 ).177 The excited state is split into two components m+ and
m , due to the interaction of two transition dipoles M1 and M2. There is a parallel arrangement

of the molecules in H-aggregates and the allowed m+ state has a higher energy than the m state
and the excited monomer (Fig. 1.14), leading to hypsochromic shift in absorbance compared to
the monomer. Note that the m+ state undergoes fast internal conversion process to the nonemitting m state accounting for quenched emission in H-aggregates and a large Stokes shift
(Figure 1.14).177 In contrast, the allowed m+ state in J-aggregates has a lower energy relative to
the monomer leading to bathochromic shift in absorbance. In addition, there is no internal
conversion to an intermediate non-emitting state and hence J-aggregates are highly fluorescent
with a small Stokes shift (Figure 1.14).
Several factors affect the type of aggregates formed including dye structure, dye
concentration, solvent polarity, pH, ionic strength, and temperature.178 It is worth noting that the
properties of dye aggregates may also be influenced by interaction with biomolecules.174 For
instance, such an interaction may enhance the low fluorescence quantum yield of H-aggregates
while quenching the more fluorescent J-aggregates. The fluorescence enhancement phenomenon
have been utilized by Gabor and coworkers for non-covalent labeling of the biomolecules.174 It is
envisaged that an understanding and characterization of the tunable aggregates formed by the
NIR nanoGUMBOS described in this dissertation will be useful in exploiting the full potential of
these novel nanomaterials.
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m-

m+

Figure 1.14. Proposed energy diagram for the formation of H- and J- dye aggregates and the
resulting absorption and fluorescence properties. The blue and red blocks represent dye
molecules, solid arrows mark the absorption, broken arrows the fluorescence and wavy arrows
the internal conversion, crossed lines are forbidden transitions. m+ and m are the splitted
excitonic states whereas only m+ is allowed for light transitions. (Adapted from reference 177).
1.7.1. Characterization of NIR NanoGUMBOS Aggregates: Fluorescence Anisotropy
In addition to UV-vis spectroscopy and steady state fluorescence spectroscopy described
earlier, fluorescence anisotropy was used in this study to determine the predominant aggregation
type in the NIR nanoGUMBOS as a function of varying the anion. We note that fluorescence
anisotropy has been used extensively to study aggregation behavior of various fluorophores.179182

Most of these studies reveal that molecular stacking in H aggregates results in slower

rotational diffusion and higher anisotropies. However, the enhanced intermolecular interactions
often lead to quenched fluorescence. In contrast, the less rigid head-to-tail arrangement in J
aggregates leads to higher rotational diffusion and lower anisotropies. Due to less intermolecular
interactions, J aggregates are usually highly fluorescent. In this dissertation, fluorescence
anisotropy for dilute GUMBOS solution and nanoGUMBOS was used to determine the
predominant aggregation behavior in the nanoGUMBOS containing various anions.
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The principle of fluorescence anisotropy is photoselective excitation of fluorophores by
polarized light.106 Figure 1.15 illustrates the measurement of fluorescence anisotropy. The
sample is excited with vertically polarized light and the emission through the polarizer is
measured. There is preferential absorption of photons with electric vectors aligned parallel to the
transition moment of the fluorophore. This process called photoselection results in polarized
emission. The intensity observed is either parallel (Ivv) or perpendicular (Ivh) to the direction of
polarized excitation.106 Anisotropy is calculated from the values of Ivv and Ivh: r = (IvvGIvh)/(Ivv+2GIvh), where G is the grating factor that has been included to correct the wavelength
response for polarization response of the emission optic and the detector. Ivv and Ivh are the
fluorescence intensity measured parallel and perpendicular to the vertically polarized excitation,
respectively. Anisotropy is dimensionless and does not depend on total intensity of the sample.106
In contrast to polarization, anisotropy is normalized to total intensity (IT): IT = Ivv-2Ivh.
Depolarization processes may be intrinsic due to inherent properties of the fluorophore or
extrinsic due to factors such as rotational diffusion and resonance energy transfer (RET).106 The
main source of extrinsic depolarization is rotational diffusion within the lifetime of the excited
state. In aqueous non-viscous solutions, the anisotropy is near zero since the molecule can rotate
extensively during the excited state lifetime. In contrast, a fluorophore bound to a
macromolecule or in a rigid microenvironment has higher anisotropy due to restricted rotation.
Resonance energy transfer (RET) also results in decreased anisotropy. RET occurs in
concentrated solutions where the average distance between fluorophores is small enough to
induce the transfer of energy between a donor and acceptor molecule. The resulting radiationless
transfer of energy reduces the anisotropy considerably. Minimizing the effects of RET simply
requires the dilution of the system being investigated. In general, fluorescence anisotropy has
been used to provide information such as size and shape of proteins, protein interactions and
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rigidity of the molecular environment.106 In this study, fluorescence anisotropy was used to
characterize the aggregates formed by NIR nanoGUMBOS when the anions are varied.

Figure 1.15. Schematic diagram depicting the measurement of fluorescence anisotropy.

1.8. Scope of the Dissertation
This dissertation has two main parts namely; the use of CILs for spectroscopic enantiomeric
recognition and the synthesis of novel fluorescent NIR nanoGUMBOS for biomedical imaging.
Chapter 1 outlines useful background information related to the dissertation work mainly
covering ILs, CILs and fluorescent NIR GUMBOS and nanoGUMBOS. In Chapter 2, the
synthesis of novel CILs and investigation of their enantiomeric recognition properties is
described. In this study enantiomeric recognition was carried out using
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F NMR and

fluorescence spectroscopy exclusively on chiral fluorescent analytes. Chapter 3 extends the
enantiomeric recognition studies to include fluorescent and non-fluorescent analytes using a
fluorescent amino acid CIL as a potential universal selector. Chapter 4 entails the preparation of
a new class of fluorescent NIR GUMBOS and nanoGUMBOS for biomedical imaging
applications. Chapter 5 focuses on the characterization of tunable aggregates formed by

39

nanoGUMBOS so as to exploit their full potential based on their tunable spectral properties.
Chapter 6 summarizes the overall conclusions drawn from the entire dissertation and provides
suggestions on future research prospects deemed feasible based on the findings described in the
dissertation.
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CHAPTER 2
SYNTHESIS AND CHARACTERIZATION OF NOVEL CHIRAL IONIC LIQUIDS AND
INVESTIGATION OF THEIR ENANTIOMERIC RECOGNITION PROPERTIES*
2.1. Introduction
Ionic liquids (ILs) are a class of organic salts that melt at or below 100°C. These
compounds typically contain an organic cation with delocalized charge and a bulky inorganic
anion. ILs that that exist in the liquid state at room temperature are termed room temperature
ionic liquids (RTILs). Interest in room temperature ionic liquids continues to grow because of
their potential as greener solvent alternatives to conventional environmentally damaging organic
solvents.1 In addition, ILs have unique properties such as lack of measurable vapor pressure,
high thermal stability, and recyclability.1-5 Such environmentally-friendly properties make ILs
relatively benign solvents for cleaner processes to minimize toxic chemical wastes which have
become a priority for chemical industries.6 Room temperature ILs have been used in various
applications such as replacing conventional organic solvents in organic synthesis7, solvent
extractions8, electrochemical reactions9,

10

, liquid-liquid extractions11 and in enzymatic

reactions.12 In addition, analytical applications of ILs such as their use as buffers in capillary
electrophoresis13, as stationary phases in gas chromatography14, 15 as well as high performance
liquid chromatography16, and enhancement of sensitivity in thermal lens measurement have also
been investigated.17 A review of several analytical applications of ionic liquids has been reported

*

Reproduced in part with permission from Chirality, 2008, 20, 151-158; Bwambok, David K.;
Marwani, Hadi M.; Fernand, Vivian E.; Fakayode, Sayo O.; Lowry, Mark; Negulescu, Ioan;
Strongin, Robert, M.; Warner, Isiah M.; Synthesis and characterization of novel chiral ionic
liquids and investigation of their enantiomeric recognition properties, copyrighted to Wiley-Liss
Inc. in 2007.
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by Baker and coworkers.18 In addition, Baker and his coworkers have developed an optical
sensor based on an ionic liquid.19
Analyses of chiral molecules are very important since different enantiomers of a chiral
racemic drug may display different properties.20 For example, one enantiomer of a chiral drug
may have the desired medicinal properties, while the other enantiomer may be harmful. Various
chiral selectors, such as cyclodextrins, molecular micelles, antibody, and crown ethers have been
widely used because of their chiral recognition abilities.21-24 However, the use of many current
chiral selectors is often limited due to low solubility, difficult organic syntheses, instability at
high temperature, as well as high cost. In addition, many currently available chiral selectors
require the use of another solvent and sometimes more than one solvent system if the analyte and
the chiral selector are not soluble in the same solvent. Therefore, there is a need for the
development of new chiral selectors that can be used simultaneously as solvent and chiral
selector. Thus, the use of chiral ILs have gained popularity since they can be used as chiral
solvents for asymmetric induction in synthesis.25 Chiral ILs can also serve as chiral stationary
phases in chromatography as demonstrated by Armstrong and coworkers in gas
chromatography.26 Tran and coworkers have also recently used chiral ILs for determining the
enantiomeric composition of pharmaceutical products.27, 28
To our knowledge, 1-butyl-3-methyl imidazolium lactate reported in 1999 by Seddon and
his coworkers is among the first chiral ionic liquids synthesized.29 This chiral ionic liquid, with a
chiral anion, was prepared via anion metathesis using 1-butyl-3-methyl imidazolium chloride and
sodium (S)-2-hydroxypropionate. This ionic liquid also afforded good endo/exo selectivity in a
Diels Alder reaction. Recently, ionic liquids with chiral carboxylates have been synthesized by
Allen and coworkers.30 This synthesis was achieved in water by reacting tetrabutylammonium
hydroxide with the corresponding amino acids or chiral carboxylic acids. In 2002, Wasserscheid
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and coworkers synthesized chiral ILs from chiral starting materials affording many different
chiral ILs in good yields.31 A novel imidazolium based chiral ionic liquid with planar chirality
was synthesized by Saigo, et al. in 2002.32 However, this ionic liquid could only be obtained as a
racemic mixture and required further separation of the enantiomers before investigating its
applications. Other chiral ILs based on imidazolium33,

34

, ephedrinium35, and pyridinium36

cations have been synthesized. However, chiral precursors for ILs are often used in a multi-step
synthesis. A detailed review of chiral ionic liquid synthesis has been reported.37 Kou, et al. have
also successfully prepared chiral ionic liquids from amino acids and their corresponding methyl
and ethyl esters.38 These chiral ionic liquids from amino acid esters had low melting points
compared to those derived from amino acids. Other interesting amino acid derived chiral ionic
liquids have also been synthesized recently.39-42 Armstrong and Ding have successfully
synthesized chiral ILs via a simple anion exchange between a commercially available halide salt
with N-lithiotrifluoromethanesulfonimide.42 This approach provides an attractive one step
synthesis with a chiral precursor, while allowing the product to be easily purified by washing
with water. The same approach was employed by Tran et al. to prepare chiral ILs.27 The variety
and applications of these ILs suggest that other chiral ILs need to be explored in order to obtain
ILs for different applications.
Natural materials are often used as precursors for preparing chiral ILs in multiple step
synthesis. As an example, the use of amino acids for preparation of imidazolium cations is clear
evidence of such use.33 Chiral induction in some reactions may be required to afford chiral ILs,
mostly in one enantiomeric form. In addition, the few commercially available chiral ILs are often
very expensive. The high cost, combined with the difficulty in chiral ionic liquid synthesis, has
limited their extensive study and applications.
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The primary objective of this study was to synthesize and characterize both enantiomeric
forms of new chiral ILs from commercially available amino acid ester chlorides. The presence of
a chiral center in the precursor further simplifies the synthesis, alleviating the need for
asymmetric induction. In addition, esterification reduces hydrogen bonding of amino acids
affording low melting point ILs.38 By varying the anions, the synthesis of ILs can be tailored,
resulting in ionic liquids of different properties that may be used for various applications. In
addition, this study reports an investigation of the enantiomeric recognition ability of a variety of
chiral amino acid ester based ILs. The synthesis of chiral ILs was accomplished via a simple
anion metathesis reaction and characterization was performed using nuclear magnetic resonance
(NMR), thermal gravimetric analysis (TGA), differential scanning calorimetry (DSC), circular
dichroism (CD), and elemental microanalysis. The relatively simple synthetic procedure and the
presence of chiral centers in the precursors is a tremendous advantage for our approach. Finally,
the chiral recognition ability of L- and D- alanine tert-butyl ester bis (trifluoromethane)
sulfonimide ionic liquid was evaluated using
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F NMR with a racemic Mosher‟s sodium salt

substrate and fluorescence spectroscopy with some chiral fluorescent analytes.
2.2. Methods
2.2.1. Chemicals and Materials
L- and D-alanine tert butyl ester hydrochloride [L- and D-AlaC4Cl)], bis(trifluoromethane)
sulfonimide lithium salt (LiNTf2), silver tetrafluoroborate (AgBF4) , silver lactate (AgLac), silver
nitrate (AgNO3), 2-methoxy-2-(trifluoromethyl) phenylacetic acid (Mosher‟s acid), and methanol
(ACS certified) were purchased from Sigma Aldrich Chemicals (Milwaukee, WI). In addition,
enantiomerically

pure

R-

and

S-

enantiomers

of

warfarin,

naproxen

and

2,2,2-

trifluoroanthrylethanol (TFAE) were purchased from Sigma Aldrich Chemicals (Milwaukee,
WI). All chemicals were used as received.
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2.2.2. General Instrumental Methods
The NMR spectra were recorded in d6-DMSO on a Bruker-250 MHz instrument with tetramethyl
silane (TMS) as an internal standard. Melting point (Tm) was determined by differential scanning
calorimeter using a thermal analysis instrument TA SDT2960 at a scanning rate of 5 °C min-1.
Thermal decomposition temperature (Tdec) of ILs was determined with a thermal analysis
instrument 2950 TGA HR V6.1A (module TGA 1000 °C). The heating rate for TGA was 5 °C
min-1 under nitrogen from 25 °C to 300 °C. A Jasco-710 spectropolarimeter was used to obtain
the CD spectra of our ILs. Steady-state fluorescence measurements were recorded at room
temperature by use of a Spex Fluorolog-3 spectrofluorimeter (model FL3-22TAU3; Jobin Yvon,
Edison, NJ, USA) equipped with a 450-W xenon lamp and R928P photomultiplier tube (PMT)
emission detector. Fluorescence emission spectra were collected in a 4 mm quartz fluorescence
cuvet with slit widths set for entrance exit bandwidths of 4 nm on both excitation and emission
monochromators for warfarin, 2 nm for TFAE, and 1.5 nm for naproxen, respectively.
Fluorescence for warfarin, TFAE, and naproxen were respectively monitored at excitation
wavelengths of 306, 365, and 280 nm. In addition, all fluorescence spectra were blank subtracted
before data analysis.
2.2.3. 19F NMR Experiment
Racemic Mosher‟s sodium salt was prepared from Mosher‟s acid by reacting with an equivalent
of sodium hydroxide in water and the salt was dried under vacuum before

19

F NMR

measurement. The racemic Mosher‟s sodium salt (8.38 mg, 0.03 mmol) and 129.07mg (0.3
mmol) of L- or D- AlaC4NTf2 were dissolved in 0.75 ml of d6 DMSO. The mixture was shaken
vigorously for 10 minutes on an orbital shaker before recording 19F NMR spectra.
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2.2.4. Synthesis of L- and D-Alanine tert Butyl Ester bis (trifluoromethane) Sulfonimide,
AlaC4NTf2
An amount of 0.5 g (2.75 mmol) of L- or D-alanine tert butyl ester chloride was dissolved in
water. An equimolar amount (0.79 g, 2.75 mmol) of bis (trifluoromethane) sulfonimide lithium
salt was dissolved separately in water. The two solutions were mixed and stirred for 2 hrs at
room temperature. The mixture resulted in two layers, of which the lower layer was separated
and dried under vacuum overnight. This resulted in 0.94g (79 % yield) of colorless ionic liquid.
Scheme 2.1 depicts the anion exchange reaction between L-alanine tert butyl ester chloride and
bis (trifluoromethane) sulfonamide lithium salt to afford CIL.
O

H

F3C

CH3

O

H3N

CH3

O

O

N

Li

S

O

+

CH3
H3C

S

F3C

Cl

O

L-AlaC4Cl

LiNTf2
H2 O
r.t., 2 hrs
79 %

H

CH3

O

H3N

CH3

O
CH3
H3C

NTf2

L-AlaC4NTf2

Scheme 2.1. Synthesis of L-AlaC4NTf2
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The decomposition temperature (Tdec) of this ionic liquid was found to be 263 °C by use of
TGA measurements. 1H NMR (250 MHz, d6 DMSO) δ (ppm) 8.19 (s, 3H), 3.97 (q, 1H), 1.45 (s,
9H), 1.36 (d, J = 7.0 Hz, 3H). 13C NMR δ (ppm) 170.12, 83.66, 49.19, 28.32, 16.69. Anal. Calcd.
for C9H16N2O6S2F6 : C, 25.35; H, 3.78; N, 6.57. Found: C, 25.07; H, 3.98; N, 6.52.
2.2.5. Synthesis of [L- and D-Alanine tert Butyl Ester] Nitrate, Tetrafluoroborate, and
Lactate
The synthesis of both enantiomeric forms of alanine tert butyl ester CIL containing nitrate,
tetrafluoroborate and lactate anions is summarized in scheme 2.2. The synthesis of L- alanine tert
butyl nitrate is described as a representative procedure to outline the experimental details of the
anion exchange reaction with these anions. The procedure is similar for tetrafluoroborate and
lactate anion exchange except we replace the nitrate anion with the corresponding lactate or
tetrafluoroborate salt.

H

CH3

O

H
H3N

MY

H3N

CH3

O
CH3
H3C

CH3

O
CH3

r.t., 5 min

Cl
L-AlaC4Cl

CH3

O

H3C

M = Ag
Y = NO3, BF4, Lac

Y
L-AlaC4Y

Scheme 2.2. Synthesis of AlaC4NO3, AlaC4BF4, and AlaC4Lac
2.2.5.1. Representative Procedure: Synthesis of L-Alanine tert Butyl Ester Nitrate
A tenth of a gram, i.e. 0.1 g (0.55 mmol) of L- AlaBuCl was dissolved in methanol. An
equimolar amount of silver nitrate (0.0935 g, 0.55 mmol) was suspended separately in methanol.
The two solutions were mixed and stirred, and the precipitate was then filtered. The product was
evaporated in vacuo and purified by crystallizing in methanol/ether to obtain 0.08 g (77 % yield)
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of the product L-AlaC4NO3 as white crystals (Tm, 104 °C). This ionic liquid was thermally stable
up to 130 °C. 1H NMR (250 MHz, d6 DMSO) δ (ppm) 8.36 (s, 3H), 3.92 (q, 1H), 1.44 (s, 9H),
1.35 (d, J= 7.0 Hz, 3H).

13

C NMR δ (ppm) 170.05, 83.51, 49.18, 28.36. Anal Calcd. for

C7H16N2O5: C, 40.38; H, 7.75; N, 13.45. Found: C, 44.97; H, 8.53; N, 9.03.
2.2.5.2. L-alanine tert Butyl Ester Tetrafluoroborate
Yield: 80%.Tm, 93 °C ; Tdec, 125 °C. 1H NMR (250 MHz, d6 DMSO) δ (ppm) 8.18 (s, 3H), 3.94
(q,1H) 1.45 (s,9H), 1.36 (d, J = 7Hz, 3H). 13C NMR δ (ppm) 170.13, 83.68, 49.19, 28.38, 16.74.
Anal. Calcd. for C7H16NO2BF4: C, 36.08; H, 6.92; N, 6.01. Found: C, 35.71; H, 7.31; N, 6.13.
2.2.5.3. L-Alanine tert Butyl Ester Lactate
Yield: 86%. Tm, 114 °C; Tdec, 132 °C. 1H NMR (250 MHz, d6 DMSO) δ (ppm) 5.53 (s, 3H), 3.79
(q, 1H), 3.62 (q, 1H), 1.40 (s, 9H), 1.25 (d, J=7 Hz, 3H) 1.15 (d, J=6.75, 3H). 13C NMR δ (ppm)
209.50, 178.31, 173.10, 110.00, 81.97, 67.28, 49.91, 28.46, 21.87, 18.98. Anal Calcd. for
C10H21NO5: C, 51.05; H, 8.99; N, 5.95. Found: C, 50.85; H, 8.96; N, 5.96.
2.3. Results and Discussion
2.3.1. Synthesis and Characterization of a New Amino Acid Ester Chiral Ionic Liquid (Lor D-AlaC4NTf2)
The synthesis of both enantiomeric forms of alanine tert-butyl ester bis (trifluoromethane)
sulfonimide was accomplished via anion metathesis reaction of the corresponding amino acid
ester chloride and bis (trifluoromethyl) sulfonylimide lithium salt (Scheme 2.1). The reaction
proceeded well in water with good yield (79%) of L - or D-alanine tert-butyl ester bis
(trifluoromethyl) sulfonylimide (L- or D-AlaC4NTf2). The 1H NMR (Fig. 2.1) and
(Fig. 2.2) of the ionic liquid was consistent with the chemical structure of AlaC4NTf2.
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13

C NMR

Figure 2.1. Proton (1H) NMR spectrum of L-AlaC4NTf2 in d6 DMSO with tetramethyl
silane (TMS) as an internal standard at room temperature.

The NMR spectra obtained for other ILs were very similar to that of AlaC4NTf2. The
similarity in NMR spectra was expected since only the anions were varied. The alanine tert-butyl
ester bis (trifluoromethyl) sulfonylimide ionic liquid was found to be a desirable liquid at room
temperature and stable up to 263 ºC, as indicated by thermal gravimetric analysis (TGA)
measurement (Fig. 2.3A).
The ionic liquid L-AlaC4NTf2 was also heated at 225 ºC for 2 hours to verify and confirm
whether decomposition occurs at a lower temperature. From Fig. 2.3B, it seems that at this
isothermal plateau (225 °C), there is a constant rate loss of 0.42%/min for the span of 120 min.
The constancy of the weight loss rate might be an indication that a physical phenomenon (e.g.
evaporation), rather than a chemical decomposition process, is occurring. The rather low
decomposition temperature for the BF4 salt (125 ºC), is still uncertain and may not be solely due
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to the cation instability upon moderate heating. This is because as much as the cation might not
be very stable at moderate heating, the same cation had relatively higher stability (263 ºC) with
the NTf2 anion.

Figure 2.2. Carbon-13 NMR spectrum of L-AlaC4NTf2 in d6 DMSO with tetramethyl silane
(TMS) as an internal standard at room temperature.

The high thermal stability of alanine tert-butyl ester bis (trifluoromethyl) sulfonylimide
makes it a preferred chiral selector and chiral solvent for reactions at high temperature or as a
coating in gas chromatography. It is indeed extremely important that the chiral center in the
precursor be retained in the final ionic liquid product. According to Jodry and Mikami, some
imidazolium CILs will sometimes undergo racemization after synthesis.34 The possibility of
racemization in the synthesized ILs was investigated by use of circular dichroism (CD)
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measurements of the ionic liquid products and their precursors. Examples of the CD bands
obtained for both enantiomeric forms of the ionic liquids are as shown in Fig. 2.4.
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Figure 2.3. Thermal gravimetric analysis of L-AlaC4NTf2 with a heating rate of 5 °C min-1 under
nitrogen (A) from 25 to 300 °C and (B) from 25 to 225 °C, then isothermally at 225 °C for 2 hrs.
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As expected, the CD bands of the precursors were in the same direction as those of the ionic
liquid products, confirming retention of configuration. In addition, the opposite CD bands
confirmed that the L- and D- configurations of the ILs had been retained (Fig. 2.4).
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Figure 2.4. Circular dichroism spectra of L- and D- (A) AlaBuCl, (B) AlaBuBF4, (C)
AlaBuNO3, and (D) AlaBuNTf2 at room temperature.
2.3.2. Chiral Recognition Study of ILs Using 19F NMR
As previously noted, L- and D- alanine tert-butyl ester bis (trifluoromethane) sulfonimide are
liquids at room temperature. It was therefore interesting to investigate their ability to act both as
solvent and chiral selector. The chiral recognition ability of L- and D-alanine tert-butyl ester bis
(trifluoromethane) sulfonimide was investigated by use of

19

F NMR and racemic Mosher‟s

sodium salt. In this experiment, various solvents such as methylene chloride, deuterium oxide,
dimethyl sulfoxide (DMSO) as well as chloroform were examined. However, d6-DMSO
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demonstrated good solubility as compared to other solvents investigated. The results of the

19

F

NMR study for enantiomeric recognition ability of L- and D- alanine tert-butyl ester bis
(trifluoromethane) sulfonimide are shown in Fig. 2.5. The change in chemical environment lead

Fig 2.5. 19F NMR spectra of (A) racemic sodium Mosher‟s salt; and a mixture of the
racemic sodium Mosher‟s salt with (B) D-AlaC4NTf2, and (C) L-AlaC4NTf2 at room
temperature.
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to a shift in the 19F NMR signal of the racemic Mosher‟s sodium salt. In addition, the split in the
19

F NMR signal of the racemic substrate by both enantiomeric forms of the ionic liquid

demonstrates their enantiomeric recognition (Fig. 2.5). This confirms that this ionic liquid can be
a suitable chiral selector for various applications such as determination of enantiomeric
composition of chiral molecules of pharmaceutical, biomedical, and environmental interest.
2.3.3. Chiral Recognition of ILs Using Fluorescence Spectroscopy
Steady-state fluorescence spectroscopy was further used to evaluate the chiral recognition
ability and enantio-selectivity of the chiral ILs on 2,2,2-trifluoroanthrylethanol (TFAE),
warfarin, and naproxen chiral analytes. The choice of these chiral analytes in this study was due
to their fluorescence properties; furthermore, they are of environmental and pharmaceutical
interest. For instance, warfarin is an anticoagulant drug used for the treatment of
thromboembolic diseases and is also generally used as a pesticide, while naproxen is used as an
anti-infammatory drug.
The emission spectra of the 10 µM R- and S-enantiomers of TFAE, warfarin, and
naproxen analytes in the presence of L-AlaC4NTf2 chiral ILs are respectively shown in Fig. 2.6
(A1, B1 and C1). The intensity of emission of the R-enantiomers obtained in the presence of
ionic liquid solvent and chiral selector is noted to be higher than that of the S-enantiomers for all
three analytes investigated. A difference in emission intensity of R- and S-enantiomers in the
presence of chiral selectors is due to different diastereomeric interactions between the
enantiomers and the IL chiral selectors. Such spectral differences have been widely reported and
associated with enantioselectivity of chiral selectors as a result of diastereomeric complexes.43-45
Finally, a mean-centered plot of emission spectra, obtained by subtracting each emission
spectrum from the mean spectrum on a wavelength to wavelength basis, was used to gain better
insight into the enantiomeric selectivity and chiral recognition ability of the chiral ILs. The mean
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centered plot of the emission spectra depicted in Fig. 2.6 (A1, B1, and C1) are shown in Fig. 2.6
(A2, B2 and C2), respectively. The spectra were obtained by subtracting the spectrum of R- and
S-enantiomer in the presence of chiral selectors from the R- and S-mean spectra. It is of great
importance to note that R- and S- enantiomers have opposite mean spectra, further demonstrating
the chiral recognition ability and enantio-selectivity of the ionic liquid chiral selector.
2.3.4. Synthesis and Characterization of Novel Amino Acid Ester CILs (L-or D-AlaC4NO3,
AlaC4BF4, AlaC4Lac)
A similar anion metathesis reaction used for the synthesis of AlaC4NTf2 was employed for the
synthesis of AlaC4NO3, AlaC4BF4, and AlaC4Lac. However, the reaction was performed in
methanol at a shorter time of five minutes (Scheme 2.2). The silver chloride precipitate was
filtered off in each case affording good yields of the respective chiral ILs after removing
methanol in vacuo. Alanine tert- butyl ester nitrate (AlaC4NO3) crystallized to form a white solid
at room temperature. AlaC4BF4 was obtained as a colorless greasy solid, whereas AlaC4Lac
forms clear needle-like crystals at room temperature. The fact that solid ILs were obtained upon
changing the anion demonstrates the tunability of the ILs synthesized in this study. By varying
the anion or cation, different ILs with different properties are obtained for various applications.
These results illustrate that bis (trifluoromethane) sulfonimide is probably a poorly coordinating
anion with an alanine tert butyl ester cation. The poor crystal packing between the anion and
cation results in ionic liquid. Del Po‟ polo describes this as frustrated packing between a bulky
inorganic anion and cation leading to lower melting point ILs.46 Their findings are in agreement
with our results that bis (trifluoromethane) sulfonimide being the largest of the anions yielded an
ionic liquid product that was liquid at room temperature. The other smaller anions such as nitrate
afforded ILs that were solid at room temperature.
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Figure 2.6. Fluorescence emission and mean centered spectral plots of 10 µM R- and
S- (A) TFAE, (B) warfarin, and (C) naproxen enantiomers in the presence of L-AlaC4NTf2 chiral
ionic liquid. The emission spectra of TFAE, warfarin, and naproxen were monitored at excitation
wavelength of 365, 306, and 280 nm, respectively, at room temperature.
2.4. Conclusions
In summary, we have successfully synthesized a series of new chiral ILs in both
enantiomeric forms using a simple metathesis reaction between the chiral chloride ester salt and
the corresponding anion sources. Alanine tert-butyl ester bis (trifluoromethane) sulfonylimide is
desirably liquid at room temperature and is thermally stable up to 263 ºC. It can therefore be
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used in high temperature reactions or as a chiral selector in gas chromatography. Furthermore,
the ILs presented here have the same chiral configuration as the chloride salt precursors
indicating that enantiomeric salts were obtained upon anion metathesis. Both enantiomeric forms
of alanine tert-butyl ester bis (trifluoromethane) sulfonylimide ionic liquid demonstrated
enantiomeric recognition of racemic Mosher‟s sodium salt. This is an advantage since the ionic
liquid can serve both as solvent and chiral selector, alleviating the need for use of
environmentally damaging solvents to dissolve the analyte. As an example, this compound could
probably be used to provide chiral selectivity in the determination of enantiomeric composition
of pharmaceutical products and in chiral separations. While the solid ILs could not be used for
this purpose, we believe that their synthesis and characterization is a step towards exploring their
potential applications.
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CHAPTER 3
A FLUORESCENT AMINO ACID-BASED CHIRAL IONIC LIQUID FOR
POTENTIAL UNIVERSAL ENANTIOMERIC DISCRIMINATION
3.1. Introduction
Enantiomers of chiral drugs often differ in their pharmacological activities and
pharmacokinetic profiles as a result of their interactions with optically active molecules in the
human body and other biological systems. For example, one enantiomer may have the desired
medicinal activity, while the other may be inactive or show a qualitatively different effect or
quantitatively different potency, and/or lead to extreme toxicity.1 Over the past decade, the
marketing of single enantiomers of chiral drugs has become more common, with single
enantiomers now being the leading component of drugs approved today.2, 3 This is partly due to
the Food and Drug Administration‟s 1992 policy statement regarding the development and
regulation of new stereoisomeric drugs4, combined with the pharmaceutical industry‟s use of
“chiral switching” strategies to manage drug life-cycles and remarket established racemates as
single enantiomers.2,

5

Thus, there is a need for the development of methods to quantitatively

determine enantiomeric purity.
Various chiral selectors have been developed for enantiomeric discrimination. These
include

cyclodextrins6-11,

antibodies12-14,

antibiotics15,

16

,

molecular

micelles17-20,

polysaccharides21-25, and crown ethers26, 27. However, the use of many of these chiral selectors is
often hindered with problems such as low solubility of either the analyte or selector in the
solvent of choice, difficult multi-step syntheses, and instability at high temperatures. Thus,
complex solvent mixtures may sometimes be required to dissolve the analyte and the chiral
selector when they are not both soluble in the same solvent. We believe that multiple solvation
interactions, as provided by ionic liquids (ILs), may provide a solution to this problem.28 For
example, a given IL may dissolve a variety of polar and non-polar analytes, while a chiral ionic
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liquid (CIL) may simultaneously induce the required chiral selectivity.29 Moreover, unlike many
other chiral selectors, CILs do not require inclusion of the analyte into a selector‟s cavity to
provide discrimination, thus adding to their universality. In addition, ILs are often quite simple to
prepare. Many one-step synthesis of ILs, including CILs, from commercially available reagents
have been reported. ILs are also known to be stable at high temperatures as evidenced through
their many uses as separation reagents in gas chromatography.30, 31 Therefore, the many useful
properties of CILs may minimize some of the problems often encountered with other forms of
chiral selectors.
Chiral ionic liquids belong to the more general class of compounds referred to as ionic
liquids or sometimes as room temperature ionic liquids. ILs are classified as organic salts whose
“frustrated packing” yields liquid salts that melt below 100 ºC. The potential utility of ILs in
analytical chemistry32,

33

, spectroscopy29, separations34-36, synthesis or catalysis37, and beyond

has been widely reviewed.38 Chiral ionic liquids are ILs in which either the cation, or the anion,
or both may be chiral. One example of a series of CILs possessing either a chiral cation, chiral
anion, or both, has been recently reported.39 The cations of these molecules consisted of an
imidazolium group, while the anions were based upon a borate ion with spiral structure and
chiral substituents. A growing interest in CILs is demonstrated by an increasing number of new
classes of CILs reported in the literature, including the amino acid-based CILs used in this work.
The synthesis, characterization, and applications of various CILs have been thoroughly described
in several recent reviews.40-44
Chiral ionic liquids have recently gained popularity in part based on their many potential
applications, e.g. their utility as chiral stationary phases in gas chromatography30,

31

, and as

additives for enantiomeric separations in micellar electrokinetic electrochromatography45 or high
performance liquid chromatography.31 The development of ILs based on amino acids which are
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chiral, biocompatible, biodegradable, and also display reduced toxicity have also increased the
popularity of CILs. Ohno and co-workers reported amino acid-based ILs composed of
imidazolium cations and amino acid anions and speculated as to their potential utility.46
Subsequently, several other reports of amino acid-based ILs have appeared. Amino acid-based
ILs were recently reviewed47, 48 with a prediction that this area of research is poised for rapid
development and expansion.48
Despite the numerous syntheses of CILs which have been reported, surprisingly only a
limited number of studies have used spectrophotometric measurements to investigate their
enantiomeric discrimination properties.29 One example can be cited which uses near infrared
absorption to determine the enantiomeric compositions of pharmaceutical products using a novel
CIL as both the solvent and selector.49 By taking advantage of the high sensitivity of
fluorescence detection, the same group extended the technique to enantiomeric determination of
intrinsically fluorescent chiral analytes, including propranolol, naproxen, and warfarin.50 In
related work, our group has recently reported the enantiomeric discrimination of amino acidbased CILs towards intrinsically fluorescent analytes.51 Yet, there continues to be a need for a
simple, universal approach to measure enantiomeric compositions at low concentrations. High
sensitivity fluorescence detection provides a possible approach. However, since many analytes
of interest display minimal intrinsic fluorescence emission, it would be advantageous to include a
fluorescent reporter as part of the IL for such an approach.
While it has been reported that many ILs, or their impurities, display fluorescence when
excited at 280-430nm, the origin of this fluorescence has not yet been explained.33 Additionally,
a series of highly photoluminescent benzobis(imidazolim) salts was recently described by
Bielawski and co-workers and an application of this new class of versatile fluorescent materials
was demonstrated by conjugating a maleimide-functionalized derivative to bovine serum
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albumin.52,

53

However, universal fluorescence detection in the measurement of enantiomeric

compositions using a CIL as the solvent, selector, and reporter, would require a fluorescent CIL.
Such a fluorescent CIL should be capable of acting simultaneously as solvent, selector, and
fluorescent reporter; thus, high sensitivity detection would also be possible for non-fluorescent
analytes. The intrinsic fluorescence of aromatic amino acids suggests possibilities for such a
fluorescent CIL.
Herein, we report the synthesis and characterization of a fluorescent amino acid-based
chiral ionic liquid, L-PheC2NTf2, and the investigation of its enantiomeric discrimination
capabilities. To the best of our knowledge, this is the first report on the use of a fluorescent CIL
as a solvent and chiral selector for enantiomeric discrimination of non-fluorescent as well as
fluorescent analytes.
3.2. Materials and Methods
3.2.1. Chemicals and Materials
L-phenylalanine ethyl ester hydrochloride [L-PheC2Cl], bis (trifluoromethane) sulfonimide
lithium salt (LiNTf2), 2-methoxy-2-(trifluoromethyl) phenylacetic acid (Mosher‟s acid),
methanol (ACS certified), Ludox® AS-40 colloidal silica (40 Wt% suspension in water),
tetramethyl silane (TMS), deuterated solvents, pure enantiomeric forms of fluorescent analytes:
2,2,2-trifluoroanthrylethanol (TFAE), 1,1′-binaphthyl-2,2′-diamine (BNA), and propranolol, and
non-fluorescent analytes: camphanic acid, serine, glucose, and mannose were purchased from
Sigma Aldrich Chemicals (Milwaukee, WI). All chemicals were used as received without further
purification. Ultrapure water (18.2 MΩ·cm) was used for all purposes and obtained from an Elga
model PURELAB Ultra water filtration system.
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3.2.2. General Instrumental Methods
A Jasco-710 spectropolarimeter was used for measuring Circular Dichroism (CD) spectra of
room temperature methanolic solutions (1 mM L-PheC2NTf2) in 1 cm quartz cells. The thermal
decomposition temperature (Tdec) was determined using a thermal analysis instrument, 2950
TGA HR V6.1A (module TGA 1000 °C), at a heating rate under nitrogen of 5 °C min-1 from 25
°C to 300 °C. The NMR spectra were recorded using a Bruker-250 MHz instrument and using
tetramethyl silane (TMS) as an internal standard. For 1H and

13

C NMR, d6-DMSO was used as

the solvent, whereas CD2Cl2 with 30% d6-DMSO was used for 19F NMR measurements.
Absorption measurements were acquired at room temperature using a Shimadzu, model
UV-3101PC UV-vis-NIR spectrophotometer with samples either in 4 mm square quartz cells, or
between two quartz plates in the case of the neat L-PheC2NTf2 film. Steady-state and frequencydomain lifetime fluorescence measurements were recorded using a Spex Fluorolog-3
spectrofluorimeter (model FL3-22TAU3; HORIBA Jobin Yvon, Edison, NJ). Excitation was
provided by a 450 W xenon arc lamp. Dual monochromators were used to select the excitation
and emission wavelengths with bandpasses of 3nm each. The integration time was set to 0.1 sec
per point, and 950 V were applied to a Hamamatsu R928 PMT. All fluorescence spectra were
ratio corrected through division by the signal from a reference detector which monitored the
lamp output.
Excitation-Emission Matrix spectra (EEMs) were collected in 4 mm square quartz cells
with excitations from 250-400nm and emission from 250-500nm using 2.5nm and 5nm step sizes
for emission and excitation, respectively. An adjacent averaging routine was performed on all
EEMs in order to improve signal quality. The fluorescence quantum yield was measured in a 1
cm path-length quartz cell with right-angle collection geometry following the comparative
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method reported by Williams et al.54 A quantum yield of 0.27 for anthracene in ethanol was used
as the reference.
Fluorescence decay times were measured using a variable frequency phase-modulation
technique. Full-sized 1 cm quartz cells were used with 330nm excitation. The emission was
collected through a 370nm long pass filter. Thirty-one logarithmically spaced frequencies were
collected over a frequency range of 10–136.9 MHz using five averages and a 10 sec integration
time at each frequency. Frequency-domain measurements were collected versus Ludox, a scatter
reference solution, which showed a lifetime of 0 nsec. Phase and modulation decay profiles were
analyzed using the Globals software package developed at the Laboratory for Fluorescence
Dynamics (University of Illinois at Urbana-Champaign). Constant phase and modulation errors
of 0.5° and 0.005 were used in analyses for consistency and ease of day-to-day data
interpretation.
3.2.3. Synthesis of L-Phenylalanine Ethyl Ester bis (Trifluoromethane) Sulfonimide (LPheC2NTf2)
The procedure was similar to that used in the preparation of alanine-based CILs previously
reported.51 Specifically, 10 g (43.53 mmol) of L-phenylalanine ethyl ester chloride (L-PheC2Cl)
was dissolved in water and mixed with an aqueous solution of 12.49 g (43.53 mmol) of bis
(trifluoromethane) sulfonimide lithium salt (LiNTf2). The mixture was stirred for more than 2 hrs
at room temperature. The ionic liquid was quite hydrophobic and did not dissolve in water. The
ionic liquid was higher in density than water and thus formed the lower layer of a bilayer system
when mixed and stirred with water. The lower layer containing L-PheC2NTf2 was separated and
washed five times with water. It was observed that as the number of washes increased, a slight
yellow color in the ionic liquid completely disappeared. Subsequently, the ionic liquid was dried
using a lyophilizer, yielding 17.49 g (83% yield) of clear, colorless, slightly viscous, but free
flowing ionic liquid. The decomposition temperature (Tdec) was determined using TGA and
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found to be 270 ºC. Characterization by 1H NMR and

13

C NMR showed the peaks consistent

with the chemical structure of the ionic liquid. 1H NMR (250 MHz, d6 DMSO) δ (ppm) 8.3 (s,
3H), 7.34-7.21 (m, 5H), 4.28 (t, J = 7.5 Hz, 1H), 4.12 (q, 2H), 3.02-3.16 (ddd, J = 6.4, 7.5, 13.2
Hz, 2H), 1.10 (t, J = 7.2 Hz, 3H). 13C NMR δ (ppm) 169.91, 135.35, 130.28, 129.44, 128.16,
62.57, 59.50, 54.02, 14.53. These results were confirmed using elemental analysis. Calculated
for C13H16N2O6S2F6 : C, 32.91; H, 3.40; N, 5.90. Found: C, 32.00; H, 3.79; N, 5.31.
3.2.4. Circular Dichroism (CD) Measurements of CIL Liquid and Precursor
A concentration of 1.00 mM (10-3 M) stock solution was prepared by dissolving the precursor, LPheC2Cl (2.29 mg) and the CIL, L-PheC2NTf2 (4.74 mg) in 10 mL of methanol. The CD
spectra were then recorded using a Jasco 710 spectropolarimeter. Methanol was used as the
blank and was substracted from the CD data of the CIL and the precursor. The retention of chiral
configuration after prolonged heating was investigated by comparison of CD spectra of 1 mM
methanolic solutions prepared from neat L-PheC2NTf2 at room temperature to that of a
corresponding CIL solution in which the neat L-PheC2NTf2 had been heated in the oven for more
than 18 hrs at 115 ºC.
3.2.5. Sample Preparation for Fluorescence Spectroscopy
A concentration of 1.00 mM (10-3 M) stock solution of R or S (or L or D)- enantiomer was
prepared by dissolving appropriate weight in 25 mL of ethanol (or water in case of glucose
analyte) using a calibrated 25 mL volumetric flask. Equal concentrations of 10 µM (10-5 M) of R
or S (or D or L)- enantiomer were prepared by pipetting 5 µL of each stock solution (10-3 M)
into a vial, allow the solvent (water for glucose and ethanol for the rest of the analytes) to
evaporate under a gentle stream of ultrapure nitrogen and finally adding 500 µL (0.5 mL) of neat
L-PheC2NTf2. This was followed by sonication for 20 mins, vortexing and finally fluorescence
measurements were made using a 4 mm cuvet after equilibrating the sample for 10 mins.
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3.3. Results and Discussion
3.3.1. Confirmation of Chirality and Stability Upon Extended Heating
One of the goals of the current study is to demonstrate the chiral discrimination of LPheC2NTf2 when used simultaneously as the solvent and selector. Therefore, the chiral integrity
of the CIL product was important as some CILs have previously been reported to undergo
racemization during synthesis, although its precursor was enantiomerically pure.55 Circular
dichroism measurements of L-PheC2NTf2 product ionic liquid (1 mM in methanol) and its chiral
starting material, PheC2Cl (1 mM in methanol), were conducted to confirm the retention of the
chiral configuration upon the ion-exchange. The CD spectral band of the L-PheC2Cl precursor is
positive (data not shown), the same shape and direction as that of the L-PheC2NTf2 product, thus
suggesting the retention of chiral configuration. It is also important to confirm the retention of
chiral configuration upon heating the CIL for an extended period of time. This was investigated
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Figure 3.1. Circular dichroism spectra of 10-3 M L-PheC2NTf2 in methanol at room temperature
(broken line), and corresponding 10-3 M L-PheC2NTf2 in methanol prepared from neat LPheC2NTf2 previously heated at 115 ºC for 18 hrs (continuous line).
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through comparison of CD spectra of 1 mM methanolic solutions prepared from neat LPheC2NTf2 at room temperature to that of a corresponding CIL solution in which the neat LPheC2NTf2 had been heated in the oven for more than 18 hrs at 115 ºC. As shown in Figure 3.1,
this CIL does not racemize after prolonged heating.
Thermal analysis by TGA revealed that L-PheC2NTf2 is stable to thermal
decomposition up to 270 ºC (Figure 3.2 A). It has been observed that upon prolonged heating,
some ILs decompose at temperatures lower than their measured decomposition temperatures.56, 57
This observation prompted us to heat L-PheC2NTf2 for 30 minutes at a constant temperature of
225 ºC. A minimal loss of mass was observed (Figure 3.2 B). Results obtained from these studies
suggest that this CIL is relatively stable when heated for a long period of time and may be
potentially suitable as a solvent medium for high temperature reactions and as a chiral stationary
phase in gas chromatography.
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Figure 3.2. Thermal gravimetric analysis of neat L-PheC2NTf2 under nitrogen, with a heating
rate of 5 °C min-1 from (A) 25 to 350 °C (B) 25 to 225°C, then isothermally at 225 °C for 30
minutes.
3.3.2. Screening of Enantiomeric Discrimination Using 19F NMR
The enantiomeric discrimination properties of L-PheC2NTf2 were investigated using the
diastereomeric interaction towards classical racemic Mosher‟s sodium salt. A binary solvent
system consisting of CD2Cl2 with 30% d6 DMSO was used to dissolve the mixture of racemic
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Mosher‟s sodium salt and L-PheC2NTf2. The 19F NMR spectrum of Mosher‟s salt in the absence
of L-PheC2NTf2 displayed only a single band at 69.803 ppm (Figure 3.3 A). Addition of LPheC2NTf2, 142.30 mg (0.3 mmol), to the racemic Mosher‟s sodium salt, 8.38 mg (0.03 mmol),
resulted in peak splitting, as well as a shift to 70.832 and 70.876 ppm (Figure 3.3 B). The
difference in the chemical shifts (Δδ) was calculated as 11 Hz. This is an indication of strong
diastereomeric interactions between the racemic Mosher‟s sodium salt and the CIL, suggesting
that L-PheC2NTf2 has good chiral discrimination ability.

Figure 3.3. Enantiomeric recognition of Mosher‟s salt by L-PheC2NTf2. 19F NMR spectra of (A)
racemic sodium Mosher‟s salt; and (B) a mixture of the racemic sodium Mosher‟s salt with LPheC2NTf2 at room temperature.
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3.3.3. Spectroscopic Properties of L-PheC2NTf2
The absorption and fluorescence properties of L-PheC2NTf2 were studied as neat CIL (Table 3.1)
and using ethanol as a solvent as needed (Figure 3.4). These data are presented in Table 3.1. Neat
L-PheC2NTf2 was observed to be colorless. A thin film of neat L-PheC2NTf2 displayed a
maximum absorption at 257nm and a spectral shape similar to the characteristic phenylalanine
amino acid absorbance. However, unlike phenylalanine and L-phenylalanine ethyl ester
hydrochloride (a CIL precursor), L-PheC2NTf2 displayed a weakly absorbing tail in its
absorption spectrum extending to wavelengths beyond 400nm as compared to the characteristic
absorption of phenylalanine. The absorption spectra of neat L-PheC2NTf2 in a 4 mm path-length
Table 3.1. Photophysical characteristics of L-PheC2NTf2.
Absorption Properties a
CIL

L-PheC2NTf2d

λmax
(nm)

257

Fluorescence Properties
Emission Properties b Lifetime (nsec) c
ε
λ
Peak(s):λem
(L mol-1 cm-1) exc
τ1
τ2
(nm)
(nm)
260
~280, 320
280
320, ~400
0.68
3.57
~95
300
~340, ~400 (0.25)
(0.61)
320
~450

τ3
12.72
(0.14)

a

Properties of neat ionic liquid. A thin film (~29 µm) of neat L-PheC2NTf2 between two
quartz plates displayed a spectral shape similar to phenylalanine. Neat ionic liquid in a 4 mm
path-length cell displayed an absorption greater than 3 at wavelengths below ~270nm, ~0.1 near
350nm, and ~0.05 at 400nm.
b

Properties of neat ionic liquid. Front face collection geometry was used in an effort to
minimize inner filter effects.
c

Properties of neat ionic liquid. Frequency-domain measurements were collected versus
Ludox, a scatter reference solution, which showed a lifetime of 0 nsec. Full-sized 1 cm quartz
cells were used with 330nm excitation. The emission was collected through a 370nm long pass
filter. Fractional contributions of each lifetime are shown in parentheses.
d

The high absorbance of the neat L-PheC2NTf2 necessitated using dilute ethanolic solutions in
the determination of its quantum yield. A quantum yield of 0.06 was calculated upon excitation
at 257nm in a 1 cm path-length quartz cell with right-angle collection geometry.
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cell (Figure 3.2) displayed an absorbance of ~0.1 near 350nm decreasing to ~0.05 at 400nm.
Absorption was greater than 3 at wavelengths below ~270nm. It is also interesting to note that
subtle differences appeared in the spectral region between 280-320nm as L-PheC2NTf2 was
diluted in ethanol (Figure 3.4).
The high absorbance of the neat L-PheC2NTf2 necessitated using dilute ethanolic
solutions in determination of its quantum yield. A quantum yield of 0.06 was calculated for LPheC2NTf2 dissolved in ethanol upon excitation at 257nm. For comparison, this value is slightly
greater than the value of 0.022 reported for phenylalanine amino acid in water. 58 It should be
noted that a low quantum yield does not preclude the use of this CIL for enantiomeric
discrimination studies. Its use as a solvent (without dilution) resulted in sufficiently high
concentration (molarity = 3.14 moles L-1, calculated based on its measured density) to obtain
more than adequate absorption and fluorescence signal.
The absorption spectrum of a thin film (~29 µm) of L-PheC2NTf2 between two quartz
plates was qualitatively similar to that of a 1 mM solution of L-PheC2Cl (a CIL precursor) in
ethanol (Figure 2). The molar absorptivity of the L-PheC2NTf2 thin film was estimated to be 95
L mol-1 cm-1 at 257nm, which is lower than that reported for phenylalanine amino acid dissolved
in H2O (195 L mol-1cm-1 at 257.5nm).59 Decreased absorption was also observed for 0.01 M LPheC2Cl (a precursor of the CIL) in H2O as compared to 0.01 M phenylalanine in H2O (ratio of
1.77 at the absorption maxima) which accounts for most of the observed decrease in absorption
for the phenylalanine-based CIL as compared to phenylalanine. The seemingly low molar
absorptivity of L-PheC2NTf2 does not pose a problem for applications outlined for this study. In
fact, high absorption values and the resulting inner filter effects presented greater difficulties.
Therefore, front face collection geometry was used for fluorescence measurements in an effort to
minimize inner filter effects. These data indicate that it was not generally practical to use
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excitation wavelengths below ~280nm where absorption of the incident excitation light was
observed to reduce the observed emission intensity.
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Figure 3.4. Absorption spectra of neat L-PheC2NTf2, various dilutions in ethanol (EtOH), and 1
mM L-PheC2Cl ionic liquid precursor in EtOH measured in 4 mm thick cell. Figure also includes
29 µM thick layer of neat L-PheC2NTf2.
The fluorescence Excitation-Emission Matrix (EEM) of L-PheC2NTf2 revealed complex
fluorescence behavior with multiple excitation and emission bands for the neat CIL. The full
EEM contour plot can be found in Figure 3.5A with a subset of emission spectra collected using
various excitation wavelengths as shown in Figure 3.5B. Although the emission intensity was
impacted by absorption of the incident light, excitation at 260nm (near the 257nm absorption
maximum of L-PheC2NTf2) revealed broad overlapping emissions with peak maxima near the
characteristic 280nm emission of phenylalanine, as well as near 320nm. The latter peak has been
previously identified as phenylalanine excimer by Leroy et al.60 Longworth had also observed
similar excimer emission for L-poly-phenylalanine in THF.61 Increasing the excitation
wavelength to 280nm reduced the impact of inner filter effects as the absorption decreased. A
prominent excimer peak at 320nm resulting from 280nm excitation provided the largest emission
intensity for excitation at any wavelength. A lower intensity emission peak near 400nm was also
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apparent upon excitation at 280nm, which became more readily observable as the excitation
wavelength increased to 300nm. At excitation of 320nm, the peak at near 400nm was the only
emission peak. Excitations greater than 320nm resulted in a red shift of this long-wavelength
emission. Concentration-based studies conducted by Leroy et al.60 clearly demonstrated excimer
emission at 320nm for a phenylalanine concentration of 0.1 M in water. However, no longer
wavelength emitting species were reported at this concentration. It is not surprising that the
extremely high phenyalanine concentration (3.14 moles L-1) occurring in neat L-PheC2NTf2
results in much more complex spectral behavior than low concentration solutions. Explaining
these complexities is beyond the scope of this present study. However, it should be noted that
imidazolium ILs have also been reported to display unconventional fluorescence behavior. In
such solutions, fluorescence emission shifted towards the red with increasing excitation
wavelength. This observation was attributed to the presence of energetically different associated
forms of the constituent ions and to a slow rate of excited state relaxation processes in the
viscous IL.62
The complexity observed in the steady-state EEMs was also displayed in time-resolved
measurements. Instrumental limitations and the high absorption of neat L-PheC2NTf2
complicated the measurements and required excitation at a longer wavelength than the 257nm
maximum absorption of L-PheC2NTf2. In an effort to minimize inner filter effects, measurements
were performed upon 330nm excitation with emission collected through a 370nm long pass
filter. Leroy, et al. reported the lifetime of phenylalanine amino acid (8x10-4 M in H2O at 20° C)
to be 6.8±0.2 nsec and observed a slight increase in decay time at increasing concentrations.60 In
this work, three lifetime components including both significantly longer (~12 nsec) and shorter
(<1 nsec) lifetimes were required to adequately model the decay of room temperature L-
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PheC2NTf2 (Table 3.1). The more complex decay observed for the phenylalanine-based CIL is
expected considering the complexity of the spectral behavior described above.
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Figure 3.5. Fluorescence of neat L-PheC2NTf2 (A). Excitation-Emission Matrix (EEM), (B)
subset of emission spectra collected with various excitation wavelengths extracted from the EEM
at various excitation wavelengths (260-360nm in 20nm intervals).

It is also interesting to note that complex spectral behavior was observed in a phenylalaninebased fluorescent chiral molecular micelle, previously reported by our group.19,

20

Long-

wavelength emission and a triple exponential decay similar to that obtained for L-PheC2NTf2
were observed.
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3.3.4. Enantiomeric Discrimination Using Steady-State Fluorescence Spectroscopy
In these studies L-PheC2NTf2 served simultaneously as solvent and chiral selector, as
well as a fluorescent reporter in the case of non-fluorescent chiral analytes. In the case of chiral
analytes possessing intrinsic fluorescence, comparisons of the spectral alterations induced upon
the analyte‟s emission as compared to those induced upon the CIL‟s emission were made.
Equal concentrations (10 µM) of either pure R- or S- (D- or L-) enantiomer of each chiral
analyte were dissolved into neat L-PheC2NTf2. All mixtures were prepared from ethanolic stock
solutions of analytes (except glucose which was prepared in water). Required amounts of analyte
stock solution were delivered into a vial; the ethanol was gently evaporated with a stream of
nitrogen, and a known volume of L-PheC2NTf2 was added to the vials. Mixtures were shaken
vigorously to ensure complete dissolution of the analytes.
Structures of L-PheC2NTf2, and all fluorescent and non-fluorescent chiral analytes used
in this study are shown in Figure 3.6. A variety of fluorescent and non-fluorescent analytes were
chosen with a wide range of chemical structures. It is interesting to note that L-PheC2NTf2 could
dissolve all of these structurally diverse analytes and at the same time induce spectral differences
between enantiomerically pure forms of each pair of analytes. Chiral ionic liquids show
discrimination by solvating, and thus requires being in the presence of the analyte.29, 49-51 For this
reason, solubility is an important factor in the formation of diastereomeric complexes. In
previous work using a phenylalanine-based molecular micelle as the chiral selector, we observed
that the addition of methanol to aqueous solutions of analyte and selector improved the
discrimination towards non-polar analytes.20 The ability of ILs to solvate a wide range of both
relatively polar and non-polar analytes may eliminate the need for this step, thus simplifying the
measurement and increasing the universality of the method.
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Figure 3.6. Chemical structures of chiral ionic liquid and chiral analytes investigated: A. selector
L-phenylalanine ethyl ester bis (trifluoromethane) sulfonimide (L-PheC2NTf2), B. fluorescent
analytes (I) TFAE (II) BNA (III) Propranolol. C. non-fluorescent analytes (I) Camphanic acid
(II) Serine (III) Glucose (IV) Mannose.

The spectral properties of neat L-PheC2NTf2 are complex, with multiple emissions upon
using different excitation wavelengths. In order to 1) measure the response of these various
emissions to the presence of a chiral analyte and to 2) measure the response from intrinsically
fluorescent analytes when present, it was essential to measure the EEM over a broad range of
excitation and emission wavelengths. The use of multiple excitation wavelengths was imperative
because many dipolar fluorescent molecules exhibit relatively strong excitation-wavelengthdependent fluorescence behavior in ILs.62 The excitation-wavelength-dependent shift of the
fluorescence maximum has been reported to be between 10-35nm.62 The dynamic stokes shift
and excitation wavelength-dependent fluorescence of dipolar molecules in room temperature ILs
has been discussed at length.63
A comparison of the emission spectrum for neat fluorescent CIL with the spectrum of
each enantiomer dissolved in L-PheC2NTf2 for a given wavelength is informative; however,
mean-centered spectral plots have also proven to be a valuable tool in the presentation of spectral
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differences induced by a chiral selector; thus providing insight into the enantiomeric composition
of mixtures.18, 19, 51 In this work, mean-centered plots (MCPs) were obtained by averaging spectra
measured when pure R- and S- (or D- and L) enantiomers were dissolved in L-PheC2NTf2 and
then these average values were subtracted from the corresponding spectra of each individual
sample on a wavelength-by-wavelength basis. MCPs are generally useful to demonstrate the
extent of chiral recognition displayed by a chiral selector towards a particular analyte, and for
rapid screening of unknown samples to identify whether they are racemic or rich in one
enantiomeric form. The best chiral selectors induce the largest spectral differences and also
display the largest magnitudes in their MCPs. MCPs of racemic mixtures will lie on the origin,
while MCPs of mixtures rich in one enantiomer will lie between the origin and the limiting value
defined by the MCP of the corresponding pure enantiomer. The magnitude of the MCPs is an
indication of the enantioselectivity displayed by a chiral selector towards a particular analyte.
In previous studies18, 19, 51 a single excitation wavelength was generally chosen near the
absorption maxima of the fluorescent analyte or fluorescent chiral selector. This greatly
simplified the presentation of data as compared to the multidimensional fluorescence excitationemission matrixes (EEMs) collected in this study. Emission spectra were collected for all
excitations between 250-400nm. For simplicity, representative excitation wavelengths were
chosen for presentation. Emission spectra of the neat fluorescent CIL and each enantiomer
dissolved in L-PheC2NTf2 was collected at excitation wavelengths of 280nm and 360nm. These
wavelengths were chosen because emission from L-PheC2NTf2 was efficiently generated.
Intrinsically fluorescent propranolol was also efficiently excited at 280nm. Long-wavelength
emission from L-PheC2NTf2 as well as emissions of intrinsically fluorescent TFAE and BNA
were generated by excitation at 360nm. We note that other wavelengths are also of interest.
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3.3.4.1. Enantiomeric Discrimination of Fluorescent Analytes
The fluorescent analytes investigated include propranolol, TFAE and BNA. TFAE and
propranolol have asymmetric carbon and hydroxyl groups, whereas BNA has axial chirality and
amine groups. Propranolol is a beta blocker commonly used for treatment of hypertension. BNA
and TFAE are often used as starting materials for asymmetric synthesis.
The presence of BNA and TFAE resulted in ~25nm red shift and slight enhancement of
the 320nm L-PheC2NTf2 emission upon 280nm excitation; however, there was minimal
enantioselectivity apparent in the resultant emission. The emission of propranolol in S-CHTA
NTf2 upon 280nm excitation has been reported near 340nm with a shoulder near 350nm.50 Its
emission in L-PheC2NTf2 is dim, although it appears to be similar to the emission reported
above. It overlaps with the 320nm phenylalanine excimer peak of L-PheC2NTf2 and possibly the
shifted emission described above if it also exists in the presence of propranolol. The longwavelength emission of CIL upon 360nm excitation in the presence of propranolol is quenched;
however, there does not appear to be appreciable enantioselectivity in this spectral region. The
emission of BNA and TFAE overlaps that of the long-wavelength L-PheC2NTf2 emission;
however, it appears that this long-wavelength CIL emission is also quenched in a similar way as
observed in the presence of propranolol and adds little to the chiral selectivity apparent in the
emissions of the fluorescent analytes in this spectral region.
A subset of mean-centered plots (excitations from 260-360nm in 20nm intervals) for
these fluorescent analytes in the presence of L-PheC2NTf2 are shown in Figure 3.7. L-PheC2NTf2
shows selectivity towards each of these diverse analytes. Of the data shown in Figure 3.7, the
greatest difference was displayed for TFAE excited at 360nm. For propranolol, the greatest
differences in emission between the enantiomers was at ~290nm. These plots demonstrate the
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wavelength-dependent selectivity. Thus, the choice of excitation wavelengths has a major impact
on the degree of selectivity.
3.3.4.2. Enantiomeric Discrimination of Non-fluorescent Analytes
Since many analytes of interest have limited or virtually no intrinsic fluorescence emission, it
would be advantageous to measure alterations in the fluorescence emission of a fluorescent CIL,
L-PheC2NTf2, caused by diasteromeric interactions with chiral analytes. The various nonfluorescent chiral analytes used for this study include camphanic acid, serine, glucose, and
mannose. Camphanic acid is a chiral auxiliary in the synthesis of aza sugars and is also used in
the resolution of chiral alcohols. Serine is a naturally occurring amino acid useful in metabolism
such as biosynthesis of purines and pyrimidines. It also plays important catalytic functions in
enzymes such as trpysin and chymotrypsin. Glucose and mannose are carbohydrates, useful
sources of energy, and are useful in protein synthesis.
The presence of the non-fluorescent analytes, clearly induced spectral alterations to LPheC2NTf2. For example, a similar ~25nm red shift and slight enhancement of the 320nm LPheC2NTf2 emission upon 280nm excitation that was described in the presence of fluorescent
analytes (BNA and TFAE) was also observed in the presence of camphanic acid. Interestingly,
while this emission displayed minimal enantioselectivity in the presence of BNA and TFAE, it
showed considerable enantioselectivity in the presence of the non-fluorescent camphanic acid.
A subset of mean-centered plots (excitations from 260-360nm in 20nm intervals) for the
non-fluorescent analytes in the presence of L-PheC2NTf2 are shown in Figure 3.8. L-PheC2NTf2
shows selectivity towards each of these analytes. Comparisons of Figures 3.7 and 3.8 reveal that
although the magnitude of differences were generally greater for 10 µM of fluorescent analytes,
the presence of 10 µM non-fluorescent analytes induced more than adequate alterations to the
emission of the fluorescent CIL solvent.
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Figure 3.7. Fluorescence mean-centered plots (MCPs) for 10 μM individual fluorescent
enantiomers in L-PheC2NTf2 presented at various excitation wavelengths (260-360nm in 20nm
intervals). A. Propranolol, B. BNA, and C. TFAE. Solid lines represent the R- (or D-)
enantiomer. Broken lines represent the S- (or L-) enantiomer.
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Figure 3.8. Fluorescence mean-centered plots (MCPs) for 10 μM individual non-fluorescent
enantiomers in L-PheC2NTf2 presented at various excitation wavelengths (260-360nm in 20nm
intervals). A. Camphanic acid, B. Serine, C. Glucose, and D. Mannose. Solid lines represent the
R- (or D-) enantiomer. Broken lines represent the S- (or L-) enantiomer. Insets zoom in the yaxis.
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3.3.5. Potential for Chemoselective and Enantioselective Fluorescent Discrimination of
Monosaccharides
Saccharide sensing is an extremely active area of research. There are a total of 16
possible aldohexose stereoisomers with D-glucose, D-galactose, and D-mannose being the three
most common hexoses present in nature. The three isomers differ only in the axial/equatorial
configuration of their hydroxyl groups. Among these, sensing of D-glucose is of particular
interest. There has been a large focus in recent years on boronic acid-based molecular receptors
since their “rediscovery” in the mid 1990s.64 While boronic acid-sugar chemistry has been
known for well over a century, the first rationally designed fluorescent photoinduced electron
transfer sensor for saccharides utilizing the boronic acid-tertiary amine interaction was reported
by the Shinkai group in 1994.65,

66

Boronic acid-based sensors have also been recently

reviewed.67 While there has been significant progress, the development of boronic acid-based
molecular receptors has been hampered by synthetic difficulties. Another potential difficulty is
the cleavage of boronic acids under relatively mild conditions.
We note that there is a large difference between the emissions of L-PheC2NTf2 in the
presence of D-glucose as compared to D-mannose. Figure 3.9 clearly demonstrates the difference
is excitation wavelength-dependent. The difference in emission between two individual sugar
solutions (D-glucose minus D-mannose) of L-PheC2NTf2 is depicted as a contour map (Figure
3.9A). A subset of slices, with various excitation wavelengths extracted from the contour map,
are also shown for clarity (Figure 3.9B). The largest difference in emission occurs near 350nm
upon excitation at 280nm. Excitations beyond ~350nm also lead to relatively large difference in
the long-wavelength CIL emission in the presence of these two compounds. Thus, L-PheC2NTf2
may show potential in the chemoselective discrimination of saccharides.
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Figure 3.9. Fluorescence intensity differences (D-glucose minus D-mannose) between 10 μM Dglucose and D-mannose enantiomers in L-PheC2NTf2. A. Contour plot, B. Subset of difference
spectra collected with various excitation wavelengths extracted from the contour plot at various
excitation wavelengths (260-360nm in 20nm intervals).

The importance of chiral discrimination of monosaccharides has also been recognized.
For example, James et al. reported the chiral discrimination of D- and L-monosaccharides using
a chiral diboronic acid which incorporated a fluorescent naphthyl moiety.68 Binding of each
enantiomer of various monosaccharides altered the fluorescence intensity of the sensor to
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differing degrees, thus allowing them to be distinguished. Other studies in this area have been
reported, for example consider the recent study of enantioselective and chemoselective
fluorescent chemosensors for sugar alcohols, such as D-sorbitol and D-mannitol.69
Not only does the CIL, L-PheC2NTf2, described herein, display selectivity between Dglucose and D-mannose. It also shows selectivity toward the individual enantiomeric forms of
each. It is informative to compare the emission spectra for glucose and mannose enantiomers in
the presence of L-PheC2NTf2 with each other, and with the corresponding emission of neat CIL.
It is apparent that when excited at 260nm, the sugars have minimal effect on the emission of LPheC2NTf2. However, at excitations greater than ~275nm, both sugars induced dramatic spectral
alterations. For example, the presence of glucose resulted in a ~25nm red shift and slight
enhancement of the 320nm L-PheC2NTf2 emission upon excitation at 280nm, with significant
enantioselectivity toward glucose enantiomers apparent in this emission. Mannose did not induce
a similar shift; rather it enantioselectively quenched the 320nm L-PheC2NTf2 emission.
Enantioselectivity toward glucose was also displayed in the long-wavelength CIL emission and
at longer excitation wavelengths; however, the quenching of this long-wavelength emission by
mannose showed no enantioselectivity. The presence of each enantiomer of the two
monosaccharides altered the fluorescence emission of L-PheC2NTf2 to differing degrees and in
differing spectral regions, thus demonstrating the potential for chemoselective and
enantioselective fluorescent discrimination of monosaccharides.

For this reason, this

phenomenon will be examined further in more detail.
3.4. Conclusions
In summary, we have synthesized and investigated the enantiomeric recognition
properties of a fluorescent amino acid-based chiral ionic liquid, L-phenylalanine ethyl ester bis
(trifluoromethane) sulfonimide (L-PheC2NTf2). Such a CIL is advantageous over previously
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reported non-fluorescent CILs, whose applications were limited to the use of less sensitive
modes of detection such as absorption, or to the use of fluorescence in discrimination of a small
subset of intrinsically fluorescent analytes. To the best of our knowledge, this is the first report
on the use of a fluorescent CIL as a solvent and chiral selector for enantiomeric recognition of
non-fluorescent as well as fluorescent analytes. Preparation of L-PheC2NTf2 was simple, using
commercially available starting materials, and the CIL was liquid at room temperature with
thermal stability up to 270 ºC. In addition, the chiral configuration was retained upon prolonged
exposure to high temperatures at 115 ºC, which is indicative of the high stability of L-PheC2NTf2
to thermal racemization, suggesting its potential as a stationary phase for chiral gas
chromatography. Chiral discrimination studies were performed using
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F NMR and steady-state

fluorescence spectroscopy. The results suggest that L-PheC2NTf2 is a potential solvent, chiral
selector, and fluorescent reporter for enantiomeric recognition of several chiral compounds with
a wide range of structures. L-PheC2NTf2 may also prove useful in the chemoselective and
enantioselective fluorescent discrimination of monosaccharides.
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CHAPTER 4
NEAR INFRARED FLUORESCENT NANOGUMBOS FOR BIOMEDICAL
IMAGING

4.1. Introduction
Near infrared (NIR) fluorescent materials have been successfully applied in areas such as
analyses and sensor development,1 laser dyes,2 organic light-emitting diodes (OLEDs),3 invisible
printing inks,4 photodynamic therapy,5 and as biomedical imaging contrast agents.6-10 For in vivo
imaging applications, the low absorption coefficient of human skin tissues in the 700–1100 nm
NIR wavelength region11 minimizes scattering and background interference, allowing for deep
tissue imaging.12 A number of NIR-emissive materials have been exploited based on their
desirable luminescence in this spectrally quiet region, especially those that fall in the nanoregime. These nanomaterials include quantum dots,13 single walled carbon nanotubes,14
lanthanides,15 fluorescent proteins,16 gold nanoshells,12 fluorophore-tagged polymers,17 and
organic dyes.18,

19

However, many of these nanomaterials have had concerns raised regarding

both their environmental safety and their cytotoxicity. For instance, quantum dots have been
reported to cause microbial toxicity20 and pose serious environmental safety concerns which are
difficult to either control or predict. In this regard, the development of alternative nanomaterials
that are biocompatible, non-toxic, and tunable, while exhibiting well-defined delivery behavior,
is highly sought.
When employed for biological applications such as imaging, fluorophores are typically
encapsulated or doped into a polymeric21 or silica22 carrier particle, primarily for purposes of
biocompatibility. However, dye encapsulation using these materials often leads to additional
challenges such as dye leakage21 and permeability problems.23 There are also concerns that the
use of surfactant stabilizers in the preparation of these particles may induce systemic toxicity. 24
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Again, an urgent need remains for the development of uniform, non-leaking, and additive-free
luminescent particles for bio-imaging.
Within our laboratories, we have recently developed an emergent class of highly
promising nano-materials we will collectively refer to as GUMBOS (Group of Uniform
Materials Based on Organic Salts). A range of stable GUMBOS can be formed in the nanoregime from ionic liquids (ILs) that melt above room temperature. In general, the low melting
points of ILs stem from the asymmetry of the component ions and the resultant poor crystal
packing,25 a feature open to design. Of course, nanoGUMBOS developed from ILs enjoy many
of the unique properties associated with this novel class of material, including negligible vapor
pressure, variable solubility, non-flammability, high thermal stability, ionic conductivity, and
recyclability.26 In the current application, however, GUMBOS formed from ionic materials that
do not comply with the traditional working definition of an IL and melt above 100 °C are also
useful building blocks in GUMBOS formation. The most attractive feature of nanoGUMBOS is
the ability to gather within the same nano-object several complementary or orthogonal
properties, leading to the prospect of developing multifunctional GUMBOS. This designer
characteristic borrows from lessons learned in IL technology, namely, that careful selection and
pairing of a functional cation with a dissimilarly functional anion leads to a tailored material
displaying bimodal properties.
In this study, we report on a new class of fluorescent nanoparticle based on the concept of
GUMBOS. These nanoparticles display uniform, stable NIR luminescence suitable for
fluorescence imaging applications. The unique spectral properties of these NIR fluorescent
nanoGUMBOS and their performance in cellular imaging studies are summarized in this work.
To the best of our knowledge, this is the first report of IL-based NIR fluorescent nanoparticles.
Our results suggest that nanoGUMBOS might offer unique possibilities for in vivo NIR
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fluorescence imaging without the need for dye carriers, providing potential as contrast agents in
other medical imaging modes as well.
4.2. Materials and Methods
4.2.1. Materials
1,1′,3,3,3′,3′-hexamethylindotricarbocyanine

(HMT)

iodide

(97%),

bis

(2-ethylhexyl)

sulfosuccinate (AOT) sodium salt (≥99%), potassium 4-(trifluoromethyl) phenyltrifluoroborate
(96%) and potassium 3,5 bis (trifluoromethyl) phenyltrifluoroborate, Sodium tetrakis[3,5bis(1,1,1,3,3,3-hexafluoro-2-methoxy-2-propyl)phenyl]borate, sodium tetrafluoroborate, sodium
tetraphenylborate and ethanol (spectroscopic grade) were purchased from Sigma Aldrich and
used as received. Triply deionized water (18.2 MΩ cm) from an Elga model PURELAB ultraTM
water filtration system was used for all preparations of IL NIR dye nanoparticles. Vero cells
were obtained from the School of Veterinary Medicine (Louisiana State University, Baton
Rouge, LA). Carbon coated copper grids (CF400-Cu, Electron Microscopy Sciences, Hatfield,
PA) were used for TEM imaging.
4.2.2. Synthesis and Characterization of NIR GUMBOS
The NIR GUMBOS (mostly ILs) were prepared using anion exchange procedures similar to
those reported in the literature.25-27 The synthesis of 1,1′,3,3,3′,3′-hexamethylindotricarbocyanine
bis (2-ethylhexyl) sulfosuccinate ([HMT] [AOT]) is described as a representative procedure. An
amount of 30 mg (0.056 mmol) of 1,1′,3,3,3′,3′-hexamethylindotricarbocyanine (HMT) iodide
and 24.86 mg (0.056 mmol) of sodium bis (2-ethylhexyl) sulfosuccinate (AOT) salt were
dissolved in a mixture of methylene chloride and water (2:1 v/v) and allowed to stir for 12hrs at
room temperature (Scheme 4.1). The methylene chloride bottom layer was washed several times
with water and the product was obtained from the organic lower layer and dried by removal of
solvent in vacuo. Further freeze drying to remove traces of water afforded 43.02 mg (93% yield)
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of [HMT] [AOT]. All GUMBOS obtained were characterized by 1H NMR (Bruker 250 MHz
spectrometer) and elemental microanalysis (Atlantic Microlab, Norcross, GA, USA). In addition,
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F NMR was used to confirm anion exchange for fluorine containing GUMBOS. Melting points

of the GUMBOS was determined using a MEL-TEMP® capillary melting point apparatus.
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Scheme 4.1. Synthesis of [HMT] [AOT] by anion exchange reaction
4.2.3. Synthesis of NIR NanoGUMBOS
The nanoGUMBOS were prepared from GUMBOS using a modified simple, additive-free
reprecipitation method similar to that used for organic nanoparticles.24,28-31 The solvents used for
preparing the nanoGUMBOS were filtered using 0.2 µm nylon membrane filters. In a typical
preparation, 100 µL of a 1 mM solution of GUMBOS precursor dissolved in ethanol was rapidly
injected into 5 mL of triply-deionized water in an ultrasonic bath, followed by further sonication
for 2 min. Post-preparation, the particle suspension was aged for 1 h in the dark.
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4.2.4. Characterization of Size and Morphology of NIR NanoGUMBOS
The average particle size and size distribution of the prepared nanoGUMBOS were obtained by
use of transmission electron microscopy (TEM) and dynamic light scattering (DLS). TEM
micrographs were obtained using an LVEM5 transmission electron microscope (Delong
America, Montreal, Canada). The NIR nanoGUMBOS dispersion (1 µL) was dropcasted onto a
carbon coated copper grid and allowed to dry in air at room temperature before TEM imaging.
4.2.5. X-Ray Diffraction Analysis of NIR NanoGUMBOS
X-ray diffraction measurements of dried nanoGUMBOS were obtained on a Nonius Kappa CCD
diffractometer by long exposures with Mo Kα radiation and rotation of samples about the
vertical axis.
4.2.6. Absorption and Fluorescence Studies of NIR GUMBOS and NanoGUMBOS
Absorbance measurements were performed on a Shimadzu UV- 3101PC UV-Vis-near-IR
scanning spectrometer (Shimadzu, Columbia, MD). Fluorescence emission was collected using a
Spex Fluorolog-3 spectrofluorimeter (model FL3-22TAU3); Jobin Yvon, Edison, NJ). A 1 cm2
quartz cuvette (Starna Cells) was used to collect the fluorescence and absorbance against an
identical cell filled with water as the blank.
4.2.7. Cellular Uptake Studies of Nano-GUMBOS by Vero Cells
HMT AOT nanoGUMBOS were used as model nanoGUMBOS for Vero cellular labeling in this
study. The choice was based on its spectral properties (absorption and fluorescence) in the NIR
diagnostic window. In addition, literature studies suggest that both the constituent ions in HMT
AOT are expected to have non-toxic properties. Specifically, HMT cation has been used in
biological optical imaging. A structurally related cyanine dye and HMT have also been used as a
probe for radionuclide and fluorescence complementary studies. In addition, the AOT anion has
been used as an emollient (“skin softener”) in the preparation of IL-active pharmaceutical
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ingredients with cations such as lidocaine (pain reliever), ranitidine (antihistamine) and
didecyldimethylammonium (antibacterial). Vero cells (isolated from kidney epithelial cell lining
extracted from an African green monkey, Cercopithecus aethiops) were used as a model cell line
for this study using HMT AOT nanoGUMBOS. The cells were maintained in Dulbecco‟s
Modified Eagle‟s Medium (DMEM) before studies. The Vero cells were then loaded into an
eight well glass plate (2.5 × 105 cells/well) and incubated with HMT AOT nanoparticles (8
µg/mL) for 24 hrs. The cells are then washed twice with phosphate buffered saline (PBS) and
immediately visualized using a Zeiss epifluorescence microscope equipped with a Zeiss digital
camera for image acquisition. Negative controls were also prepared by loading the Vero cells
into the wells which did not contain dye.
4.3. Results and Discussion
4.3.1. Synthesis, Characterization and Optical Properties of NIR GUMBOS and
NanoGUMBOS
The GUMBOS presented in this dissertation were produced from a cationic NIR core unit
following a modification of anion exchange procedures reported elsewhere.27-29 We selected for
this study, the cationic NIR-emitting cyanine dye 1,1′,3,3,3′,3′-hexamethylindotricarbocyanine
(HMT) iodide. An example of an anion exchange reaction between HMT iodide and sodium bis
(2-ethylhexyl) sulfosuccinate (AOT) is shown in Scheme 4.1. The various anions used in the
formulation of our GUMBOS were selected for their varying hydrophobicities, geometries, and
masses. All GUMBOS obtained were characterized by nuclear magnetic resonance (NMR) and
elemental microanalysis and yielded results consistent with expectations.
As expected, the resulting NIR-emitting GUMBOS displayed variable physical
properties (melting point, solubility) dependent upon variations in the anion (Table 4.1). This
illustrates the tunability of our GUMBOS, allowing the design of a variety of physicochemical
properties targeting select applications. In general, we found that the melting point decreased
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with an increase in the size of the anion. For instance, HMT (Scheme 4.2) with a relatively
smaller 4-(trifluoromethyl) phenyltrifluoroborate anion had a melting point of 98°C whereas the
melting point decreased to 58°C when a larger AOT anion was used (Table 4.1). This
observation is consistent with that of Larsen and coworkers who investigated the factors that
affect melting point for imidazolium ILs.30 The authors concluded that the reduced crystal
packing efficiency resulting from large anion incorporation played a profound role in depressing
the melting point. Additionally, alkylation of the anion further frustrated the ion packing, causing
a further drop in the melting point.30 It is worth noting that databanks and semi-empirical models
to predict melting points of ILs have been published.31 References such as these serve as
valuable resources when considering the design and synthesis of future GUMBOS.
The solubility of ILs in water has been shown to be highly dependent on the choice of the
anion.32 As expected, the miscibility of the various GUMBOS with water was also highly
variable and dependent on the anion used in GUMBOS formation. The water-immiscible
GUMBOS are suggestive of poor hydrogen bonding interactions, as exemplified by [HMT]
[AOT]. However, some GUMBOS based on relatively hydrophilic iodide and boron-containing
anions such as tetrafluoroborate showed enhanced aqueous solubility, possibly a consequence of
the additional hydrogen bonding afforded by the degree of fluorination. In addition, the electronwithdrawing properties of fluorine may induce dipole moments, resulting in dipole–induced
dipole interactions with the surrounding water molecules.33 This postulate is supported by the

Scheme 4.2. Structure of HMT NIR dye cation
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Table 4.1. Melting points and aqueous solubilities of [HMT+]-derived GUMBOS with various
anions.
NIR GUMBOS

Anion structure

HMT NTf2

mp
(°C)
220

HMTBETI

202

×

HMT BF4

175

√

HMT TFPB

125

√

HMT TPB

96

×

HMT 4-CF3BF3 Phe

98

√

HMT 3,5-CF3PheB

95

×

HMT (OCH3)4PheB

70

×

HMT AOT

58

×
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solubility
water
×

in

aqueous solubility trend observed when comparing the mono- and di- trifluoromethyl substituted
GUMBOS formed from 4-(trifluoromethyl) phenyltrifluoroborate and 3,5 bis (trifluoromethyl)
phenyltrifluoroborate, respectively. In the latter case, the water immiscibility of HMT containing
the 3,5 bis (trifluoromethyl) phenyltrifluoroborate anion may be attributed to a reduced net
dipole moment arising from symmetric trifluoromethyl substitution.
In each case, solutions of GUMBOS based on the [HMT+] cation were excellent absorbers of
NIR irradiation. An example of this observation is shown in Figure 4.1A for a 1.0 µM ethanolic
solution of [HMT][AOT] GUMBOS, where peak absorption occurs at 743 nm. As a result of the
parent HMT cation, the GUMBOS fluoresce strongly in the NIR region, peaking near 765 nm;
with the fluorescence excitation and emission spectra following the mirror-image rule (Figure
4.1B) as expected from the Franck-Condon principle. As an example, the structure of the NIR
emitting [HMT+] cation with bis (2-ethylhexyl) sulfosuccinate [AOT–] anion is shown at the top
of Figure 4.1. Note that the focus in this chapter is on the spectral properties and cellular labeling
using HMT AOT as model NIR nanoGUMBOS. Detailed investigation of the spectral properties
of all the GUMBOS and nanoGUMBOS will be discussed in the next chapter.
In the initial report on the preparation of nanoGUMBOS, we set forth a precedent for
employing frozen ILs to manufacture size-controlled nanoparticles.34 In our earlier study, we
developed a “melt-emulsion-quench” approach for the controllable formation of particles with
average diameters spanning the 45 to 3000 nm range. In the current work, the preparation of
nanoGUMBOS was achieved using a modified reprecipitation method,35-39 which is simpler to
implement and more rapid. In a typical preparation, 100 µL of a 1 mM solution of GUMBOS
precursor dissolved in ethanol was rapidly injected into 5 mL of triply-deionized water in an
ultrasonic bath, followed by further sonication for 2 min. The ethanolic pre-GUMBOS solution
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Figure 4.1. (A) Absorbance profile and (B) fluorescence excitation and emission spectra for 1.0
µM [HMT][AOT] in ethanol; λex = 743 nm, λem = 765 nm.
and water were both filtered prior to preparation of the nanoparticles using 0.2 µm nylon
membrane filters. Post-preparation, the particle suspension was aged for 1 h in the dark. The
average particle size and size distribution of the prepared nanoGUMBOS were obtained by use
of transmission electron microscopy (TEM) and dynamic light scattering (DLS). We note that
most of the water miscible solvents such as acetonitrile, tetrahydrofuran, dimethyl sulfoxide, Nmethyl pyrrolidinone, and acetone may be used in reprecipitation to obtain nanoGUMBOS
dispersed in water. The reprecipitation synthetic method yields primarily spherical or slightly
ovate nanoparticles as confirmed by TEM. A representative TEM micrograph of nanoGUMBOS
with an average particle diameter of 79±18 nm is shown in Figure 4.2A. The polydispersity
index obtained for these samples by use of DLS was generally quite good, usually under 0.100.
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Figure 4.2. (A) TEM micrograph of [HMT][AOT] fluorescent NIR nanoGUMBOS with an
average diameter near 79±18 nm; the inset shows a selected area electron diffraction pattern
(SAED) for the [HMT][AOT] GUMBOS. (B) Absorbance spectrum of the [HMT][AOT]
nanoparticles illustrated in panel A, and (C) comparison between the fluorescence emission
spectrum of the freely dissolved [HMT][AOT] IL (1.0 µM in ethanol; red profile) and
[HMT][AOT] nanoGUMBOS (blue profile) for matched absorptivity at the excitation
wavelength (λex = 743 nm).
The prepared NIR-emitting nanoGUMBOS displayed optical properties which were
strikingly different from that of the initial ethanolic dye solution. The absorbance spectra for our
nanoGUMBOS were generally broad and bimodal, extending to significantly lower wavelengths.
For example, the absorbance of the [HMT][AOT] suspension was very broad, spanning from
well below 600 nm to well over 800 nm (Figure 4.2B). When measured at an equivalent
absorbance value, the emission intensity for the nanoparticle suspension was slightly lower and
hypsochromically shifted by roughly 8 nm as compared to the parent compound dissolved in an
EtOH solution (Figure 4.2C). This observation is highly characteristic of dye aggregation,35, 40 in
this case reflecting intermolecular interactions between [HMT+] units. Decreased fluorescence
intensity has also been observed for highly crystalline systems as a result of enhanced internal
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conversion processes.35, 40 However, we can essentially rule out this possibility as powder X-ray
diffraction measurements (data not shown) of the dried nanoGUMBOS reveal that the particles
are in fact predominantly amorphous (see also the SAED pattern inset in Figure 4.2A).
If the [HMT+]-derived nanoGUMBOS are dried and then redissolved in ethanol, they
retain the spectral characteristics of the parent solution (Figure 4.3). This observation supports
our contention that the remarkable variations in both absorbance and fluorescence properties
wholly arise from the aggregation state of the [HMT+] within the nanoGUMBOS material. This
also demonstrates that the intrinsic spectroscopic properties and chemical identity of the
GUMBOS precursor („monomer‟ ion units)

Figure 4.3. Normalized (A) absorbance and (B) fluorescence emission spectra of [HMT][AOT]
(1.0 µM solution in EtOH; solid curve), and GUMBOS from Figure 4.2A redissolved in EtOH
(dashed curve).

remain unaltered during nanoparticle formation. This observation is important when considering
the potential of GUMBOS for use as drug delivery and therapeutic vehicles.
4.3.2. Cellular Uptake of NanoGUMBOS
In order to demonstrate the potential of nanoGUMBOS as contrast agents for biomedical
imaging applications, we examined cellular uptake and fluorescence images of these particles
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using monkey kidney fibroblast (Vero) cells. Vero cells have previously been used for screening
E. coli toxin and can serve as host cells for viruses as well as eukaryotic parasites. In the present
study, Vero cells were used as model cells to investigate the cellular uptake of our
nanoGUMBOS. Using an epifluorescence microscope, we captured fluorescence images
revealing that [HMT][AOT] nanoGUMBOS can be internalized and subsequently visualized
within viable Vero cells after 24 h of incubation (Figure 4.4). These studies suggest the exciting
potential of using nanoGUMBOS in cellular imaging. The apparent homogeneous fluorescence
suggests that the nanoGUMBOS distribute nonspecifically inside the cells and are primarily
located within the cytoplasm. The uptake of the nanoparticles is presumably due to the well

Figure 4.4. Cellular uptake studies using a monkey kidney fibroblast (Vero) cell line. (A) A
phase contrast micrograph and (B) the corresponding fluorescence image of Vero cells incubated
for 24 h with 8.0 µg mL–1 [HMT][AOT] nanoGUMBOS. The fluorescence was collected using a
propidium iodide (PI) filter set: λex = 540 nm; λem = 617 nm long pass. Scale bars in (A) and (B)
are 10 µm.

known adsorptive endocytosis process previously demonstrated for mesoporous silica
nanoparticles;41 however, the exact cell-penetrating mechanism and localization of the
nanoparticles is currently under investigation.
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4.4. Conclusions
In summary, we have synthesized and investigated preliminary spectral and cellular
uptake properties of a novel series of NIR fluorescent nanoscale ionic materials we term
nanoGUMBOS. By appropriate selection of a cationic NIR dye, these fluorescent nanoparticles
were designed to exhibit absorbance and luminescent properties in the tissue-accessible NIR
region of the electromagnetic spectrum. In this study, nanoGUMBOS 79±18 nm in diameter
were fabricated by use of a simple, rapid, repeatable, and additive-free reprecipitation method
requiring neither special nor costly laboratory apparatus. Beyond the ease of preparation, this
work presents an entirely new direction for preparing contrast agent nanoparticles directly from
tailored ionic materials. Our approach alleviates current problems associated with dye leakage
and other challenges encountered in dye encapsulation, as well as obviating intensive
purification steps required when surfactants are used to prepare dye nanoparticles. It is also
noteworthy that the spectral properties of our GUMBOS deviate markedly from the freely
dissolved dye present in solution. Thus, the possibility for tuning the optical properties of
GUMBOS by variation in the parent ions offers a unique and exciting advantage for these
nanomaterials. It was also demonstrated that these NIR fluorescent nanoparticles could be
efficiently taken up in vitro by Vero cells, suggesting intriguing potential for non-invasive
biomedical imaging. Even more exciting is the prospect of tailoring nanoGUMBOS for delivery
into designated cellular structures. In any case, examination of the data presented for these
cellular studies highlights a new potential for biomedical imaging using NIR fluorescent
nanoGUMBOS.
It should be possible to extend the findings from this investigation to fashion GUMBOS
combining diverse functionalities (e.g., redox, superparamagnetic, luminescent, thermochromic,
ligating) in order to arrive at truly multifunctional hybrid materials. One could easily envision
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future polyfunctional nanoGUMBOS with applications including targeted diagnosis and therapy,
photothermal cancer therapy, scintillators, radiosensitizers, biological separations, solar cells,
and materials with defense applications (e.g., microwave-absorbers, security barcodes). The
incorporation of high atomic number elements such as iodine or gold may enable their use as
contrast agents for X-ray computed tomography (CT) scans. Likewise, GUMBOS carrying
gadolinium chelates may open up potential for clinical diagnosis by use of magnetic resonance
imaging (MRI).
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CHAPTER 5
SPECTRAL PROPERTIES OF TUNABLE AGGREGATES FROM NIR
FLUORESCENT NANOGUMBOS
5.1. Introduction
In the process of exploring NIR nanoGUMBOS for biomedical imaging in the previous
chapter, some striking observations were made in regard to the absorbance and fluorescence
spectral properties of these NIR nanoGUMBOS. Conspicuous among these intriguing spectral
properties is the broad absorption spectrum of the NIR nanoGUMBOS compared to the dilute
GUMBOS solution. Such spectral differences have been associated with and may be due to
formation of molecular self assemblies within the dye nanoparticles.1 This observation prompted
the investigation undertaken in this chapter to characterize the type of aggregates that may be
formed by the NIR fluorescent nanoGUMBOS as a function of varying the anion. To reiterate,
GUMBOS are largely frozen ILs and some have melting points in excess of 100°C. It is
therefore expected that the GUMBOS and the corresponding nanoGUMBOS will enjoy the
unique properties of ILs such as negligible vapor pressure, high thermal stability and tunability.2
In addition, the GUMBOS and nanoGUMBOS will exhibit their intrinsic properties suitable for
various applications.
As far as is known, there are two types of molecular dye aggregates namely, J and Haggregates. The J-aggregates (also known as Scheibe aggregates) were discovered independently
in 1936 by Jelly3 and Scheibe.4 In this pioneering work, a high concentration of a
pseudoisocyanine dye investigated exhibited a narrow red shifted absorption band compared to
the monomer. In addition, the fluorescence emission had narrow band and small Stokes shift.
Initially Scheibe postulated that this was due to reversible polymerization of chromophores.4
This observation is now ascribed to strong coupling between transition dipole moments of the
molecules resulting in excitonic states upon optical excitation.5, 6
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Conceptually, the molecules are arranged in a “brickwork” manner (head-to-tail
arrangement) in J-aggregates whereas in H-aggregates, the molecules exhibit “card-pack”
arrangement (face-to-face stacking).7 In general, the type of aggregate formed determines the
type of transitions from the excitonic interactions between electronically coupled chromophores.
Since their inception, considerable attention has been paid to molecular dye aggregates due to
their potential applications in various fields such as light harvesting8-10, photovoltaics8, 11, 12 and
light emitting diodes.13,

14

In addition, the possibility of both H and J aggregates exhibiting

superradiance, a phenomena resulting from cooperative emission has sparked tremendous
interest in studies of molecular self assemblies.15, 16
The aggregation phenomena has been well explained by the exciton theory illustrated by
the energy level diagram (Figure 1.14).17, 18 In general, the type of aggregate formed determines
the type of transitions from the excitonic interactions between electronically coupled
chromophores. Large hypsochromic shift in absorption typical for dye H-aggregates is attributed
to transition dipole interactions between two or more chromophores (H-aggregates) arranged
parallel to each other with a small dislocation. The excited state is split into two components, due
to the interaction of two transition dipoles. In this type of molecular assemblies, transition from
ground state to higher energy state is allowed and hence the hypsochromic shift in absorbance
and large Stokes shift in emission.17 In addition, fast internal conversion process from higher
energy state to a non-emitting intermediate state leads to quenched emission in H-aggregates. In
contrast, the allowed higher energy state in J-aggregates has a lower energy relative to the
monomer leading to bathochromic shift in absorbance. In addition, there is no internal
conversion to an intermediate non-emitting state and hence J-aggregates are highly fluorescent
with a small Stokes shift.17
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Several factors affect the type of aggregates formed including dye structure, dye
concentration, solvent polarity, pH, ionic strength, and temperature.19, 20 It is worth noting that
the properties of dye aggregates may also be influenced by interaction with biomolecules.7 For
instance, such an interaction may enhance the low fluorescence quantum yield of H-aggregates
while quenching the more fluorescent J-aggregates. The fluorescence enhancement phenomenon
has been utilized by Gabor and coworkers for non-covalent labeling of the biomolecules. The
ability to control the type of molecular aggregation for desired applications is one of the major
challenges in the field of supramolecular chemistry. Supramolecular assemblies result from
various non-covalent interactions such as electrostatic, hydrogen bonding, solvophobic and π-π
stacking interactions. Several strategies have been employed to afford control of the type of
aggregation. For instance, intramolecular heavy atom modification has been performed to
prevent aggregation of a series of NIR tricarbocyanine dye commonly used as biological
probes.21 The formation and spectral properties of dye aggregates have been controlled by use of
various additives such as salts22-24, surfactants22, reverse micelles25, polymers26, and proteins.27
Due to the aforementioned challenge of controlling the dye aggregation, organic
fluorescent nanomaterials have recently attracted considerable interest because of the possibility
of functionalization that may afford control of the resultant aggregates. Organic fluorescent
nanomaterials have also found applications such as in OLEDs.28,

29

However, research on

fluorescent organic nanoparticles is still in its infancy compared to their fluorescent inorganic
counterparts that have been widely used in applications such as fluorescent biological labels30,
photovoltaic cells31, light-emitting diodes32, 33, and optical sensors.33
A number of reports on fluorescent organic nanoparticles mostly prepared using
reprecipitation method have recently appeared.22-26 For example, Yao and coworkers have
designed pyrazoline nanoparticles and determined their size dependent spectral properties.34
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They observed a bathochromic shift in absorption transition and hypsochromic shift in emission
of the nanoparticles with increasing size and attributed it to the restraint of vibronic relaxation
and configurational reorganization.34 The organic molecules which are highly fluorescent in
dilute solutions, mostly show significant quenching of fluorescence in the solid state due to
increased intermolecular interactions.28 In addition to intermolecular interactions, such
fluorescent switching in organic nanomaterials may also be due to conformation change or
intramolecular planarization. Several studies in the last few years reported the preparation of
fluorescent dye nanoparticles and explained its fluorescent properties as an effect of Jaggregation35 or sometimes absence of aggregation within the particle.36 As aforementioned,
significant amount of work has been done in an attempt to control the aggregation behavior in
dye assemblies in solutions, solid films, or nanoparticle templates. However, to our knowledge,
there is no report on the control of aggregation within the dye nanoparticle itself. This study
seeks to unveil a novel, simple method of controlling the aggregation within the NIR
nanoGUMBOS by varying the anion. Considering that the H and J aggregates have interesting
applications unique to their spectral properties, controlling the type of aggregation within the dye
nanoparticle is highly desirable. The possibility of achieving such unprecedented controlled
aggregation with the same chromophore may provide tremendous potential of a single dye being
used in various applications; the exact reason for undertaking this study. The goal of this study is
to explore this possibility by determining the changes in spectral properties and the aggregation
behavior of fluorescent NIR GUMBOS and nanoGUMBOS as a function of varying the anion.
5.2. Materials and Methods
5.2.1. Materials
1,1′,3,3,3′,3′-hexamethylindotricarbocyanine

(HMT)

iodide

(97%),

bis

(2-ethylhexyl)

sulfosuccinate (AOT) sodium salt (≥99%), lithium bis(trifluoromethane) sulfonimide, potassium
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3,5 bis (trifluoromethyl) phenyltrifluoroborate, Sodium tetrakis[3,5-bis(1,1,1,3,3,3-hexafluoro-2methoxy-2-propyl)phenyl]borate, and ethanol (spectroscopic grade) were purchased from Sigma
Aldrich and used as received. Lithium bis(pentafluoroethane) sulfonimide (LiBETI) was gladly
donated by Gary Baker (Oakridge, TN). Triply deionized water (18.2 MΩ cm) from an Elga
model PURELAB ultraTM water filtration system was used for all preparations of NIR
nanoGUMBOS. Carbon coated copper grids (CF400-Cu, Electron Microscopy Sciences,
Hatfield, PA) were used for TEM imaging.
5.2.2. Synthesis and Characterization of NIR GUMBOS and NanoGUMBOS
The NIR GUMBOS (mostly ILs) were prepared using anion exchange procedures similar to
those reported in the literature and as described in the previous chapter. The nanoGUMBOS
were prepared from GUMBOS using a modified simple, additive-free reprecipitation method
similar to that used for organic nanoparticles and explained in chapter 4 of this dissertation.
Briefly, 100 µL of a 1 mM solution of GUMBOS precursor dissolved in ethanol was rapidly
injected into 5 mL of triply-deionized water in an ultrasonic bath, followed by further sonication
for 2 min. Post-preparation, the particle suspension was aged for 1 h in the dark.
5.2.3. Characterization of NIR NanoGUMBOS
The average particle size and size distribution of the prepared nanoGUMBOS were obtained by
use of transmission electron microscopy (TEM) and dynamic light scattering (DLS). TEM
micrographs were obtained using an LVEM5 transmission electron microscope (Delong
America, Montreal, Canada). The NIR nanoGUMBOS dispersion (1 µL) was dropcasted onto a
carbon coated copper grid and allowed to dry in air at room temperature before TEM imaging.
X-ray diffraction measurements of dried nanoGUMBOS were obtained on a Nonius Kappa CCD
diffractometer by long exposures with Mo Kα radiation and rotation of samples about the
vertical axis.
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5.2.4. Absorption and Fluorescence Studies of NIR GUMBOS and NanoGUMBOS
Absorbance measurements were performed on a Shimadzu UV- 3101PC UV-Vis-near-IR
scanning spectrometer (Shimadzu, Columbia, MD). Fluorescence studies were performed using a
Spex Fluorolog-3 spectrofluorimeter (model FL3-22TAU3); Jobin Yvon, Edison, NJ). A 0.4 cm
quartz cuvette (Starna Cells) was used to collect the fluorescence and absorbance against an
identical cell filled with water as the blank. The absorption and emission spectra were
deconvoluted using a Spec32 software based on principal component analysis and fits with
chisquare values as low as the order of 10-5 were accepted. The absorption spectra were
deconvoluted using a Gaussian fit and the emission spectra using a Lorentzian fit.

Both

normalized and unnormalized spectra were deconvoluted using this software and it was observed
that the ratio of all the three components in each spectrum remained the same in both the cases.
The contribution from each component was calculated considering it to be proportional to the
area under the corresponding component of the deconvoluted spectra.
5.3. Results and Discussions
5.3.1. Synthesis and Characterization of HMT NIR GUMBOS and NanoGUMBOS
As explained earlier in the previous chapter, the resulting NIR-emitting GUMBOS
displayed variable physical properties (melting point, solubility) dependent upon variations in the
anion. This illustrates the tunability of our GUMBOS, allowing the design of a variety of
physicochemical properties targeting select applications.
The water insoluble GUMBOS were used to fabricate nanoGUMBOS dispersed in water,
and a detailed investigation of their spectral properties as a function of varying the anion is
investigated in this chapter of the dissertation. Once again, the structure of HMT cation used
(Scheme 5.1) and the anions used (Table 5.1) are as shown.
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Scheme 5.1. Structure of HMT NIR dye cation

Table 5.1. Chemical structures of the aqueous insoluble [HMT+]-derived GUMBOS with
various anions used.
NIR GUMBOS

Anion structure

HMT NTf2

solubility
water
×

HMTBETI

×

HMT 3,5-CF3PheB

×

HMT (OCH3)4PheB

×

HMT AOT

×

in

5.3.2. TEM Characterization of NanoGUMBOS
TEM was performed as reported in the previous chapter. To reiterate, TEM
characterization showed that the nanoGUMBOS are mainly spherical as further confirmed by
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electron diffraction patterns. This suggests the amorphous nature of the nanoGUMBOS. Such
amorphous character of nanoparticles has been reported to minimize quenching from internal
conversion processes commonly observed in crystalline systems. This information is of
significance to the study in this chapter because it prompted the investigation of the underlying
factors that maybe influencing the spectral properties of nanoGUMBOS such as aggregation;
which is the subject of this study.
5.3.3. UV-visible Absorption Properties of HMT NanoGUMBOS
The UV-visible absorption spectra of dilute ethanolic solutions of all the HMT GUMBOS
with various anions are virtually overlapping (Fig 5.1). In addition, the maximum absorption is at
the same wavelength (743 nm) as the ethanolic solution of [HMT][I] precursor. This indicates,
HMT cation retain its intrinsic NIR optical properties after anion exchange to form HMT
GUMBOS. In contrast, upon fabrication of nanoGUMBOS via reprecipitation in water,
strikingly different absorption spectra were observed. In general, broad absorption spectrum was
observed for all nanoGUMBOS but the spectral shape was unique for each nanoGUMBOS (Fig
5.2). The broadening of the absorption spectra extended to both longer and shorter wavelength
regions compared to the monomeric dilute HMT GUMBOS solution. Specifically for
[HMT][AOT], [HMT][NTF2] and [HMT][3,5-(CF3)2PhBF3 nanoGUMBOS, the spectra seems to
develop absorption shoulders in both the red and blue region with respect to the absorbance of
the monomer. The broadness of the absorption band is considered to be either due to
superposition of the absorption bands of preoriented molecules around 735 nm and the formed
aggregates or due to the oscillation or rotation of the aggregates beyond the resolution of the
spectrometer.
A better insight into the intriguing absorption spectra of the nanoGUMBOS was gained
by deconvolution of the spectra using software based on principal component analysis.
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Figure 5.1. Absorption spectra of dilute ethanolic solutions (1 µM) of HMT GUMBOS
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Figure 5.2. Absorption spectra of HMT nanoGUMBOS
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Interestingly, the resolved absorption spectra reveal that each absorption spectrum is
composed of three bands which maybe assigned to three different types of absorbing species
(Fig. 5.3). The component absorbing near 735 nm is assigned to those aggregates in the
nanoGUMBOS whose transition dipoles are randomly oriented and are expected to absorb in the
monomer region (recall that the dilute ethanolic solutions of HMT GUMBOS absorbance peaks
near this wavelength). The bathochromically shifted component absorbing near 753-783 nm is
assigned to the J-type of aggregates in which the transition dipoles are arranged in a head-to–tail
manner. On the other hand, the hypsochromically shifted absorbance in the range 580-672 nm
maybe assigned to the H-type of aggregates in which the transition dipoles tends to align parallel
to each other.
It can be deduced from the deconvoluted absorption spectra (Figure 5.3), that H-type, J-type and
randomly oriented aggregates were formed in relatively different proportions. This may explain
the differences in broad shapes of the absorption bands for different nanoGUMBOS as a function
of varying the anion. It is observed that in [HMT][AOT], [HMT][NTF2] and [HMT][3,5CF3PhBF3] nanoGUMBOS, the J-component predominates over the H-component (Figure 5.3).
In contrast, the H-components are predominant in HMTBETI and [HMT][(OCH3(CF3)2)2Ph4B]
nanoGUMBOS (Figure 5.3). It is also observed that among the three dyes with predominant Jaggregates the contribution of the randomly oriented species is maximum for [HMT][3,5-(CF3)2
PhBF3] followed by [HMT][AOT] and [HMT][NTF2]. These J/H ratios and contributions from
the randomly oriented species play a profound role in influencing the fluorescence emission
properties of the nanoGUMBOS.
5.3.4. Fluorescence Emission Properties of HMT NanoGUMBOS
Steady state fluorescence results were complementary to absorption studies (both
resolved and non-resolved spectra). All HMT GUMBOS ethanolic dilute solutions displayed
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Figure 5.3. Resolved absorption spectra of HMT (A) AOT (B) NTf2 (C) 3, 5-CF3 (D) BETI (E)
OCH3 nanoGUMBOS
comparable fluorescence intensities with emission maxima at 765 nm (Figure 5.4A).
Surprisingly, the nanoGUMBOS dispersed in water had variable emission properties based on
the anion used in the GUMBOS. Specifically, the [HMT][AOT] and [HMT][3,5-CF3PhBF3]
nanoGUMBOS were found to be the most fluorescent (Figure 5.4B). This was followed by
[HMT][NTF2] nanoGUMBOS with modest fluorescence emission intensity (Figure 5.4B).
However,

the

[HMT][BETI]

nanoGUMBOS

were

weakly

fluorescent

and

[HMT][(OCH3(CF3)2)2Ph4]B nanoGUMBOS being virtually non-fluorescent (Figure 5.4B).
Approximately 10 nm blue shift in the emission maxima of the nanoGUMBOS compared to that
of ethanolic solution is probably due to the negative solvatochromic effect.
Considering the three species of the resolved absorption spectra, the major contribution to
fluorescence emission comes from the randomly oriented component and the J-component. Thus
though the HMT NTF2 nanoGUMBOS has higher J/H ratio compared to HMT 3,5-CF3PhBF3
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(Figure 5.5), the latter has relatively better fluorescence yield due to the highest contribution
from the randomly oriented component (Figure 5.6). It is therefore not surprising that HMT AOT
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Figure 5.4. Fluorescence emission properties of HMT (A) GUMBOS (1 µM ethanolic solution)
and (B) nanoGUMBOS
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nanoGUMBOS with the highest J/H ratio and significant contribution of randomly oriented
species (Figure 5.5 and 5.6) is the most fluorescent in the series. The weak fluorescence behavior
of HMT BETI may be due to the lower J/H ratio (<1) and higher contribution from H-type of
aggregates. Whereas the lowest J/H (<1) ratio and the highest contribution from H-component of
the HMT [OCH3(CF3)22Ph]4B nanoGUMBOS (Figure 5.5) may account for the extremely
quenched fluorescence emission.
The emission spectra of the nanoGUMBOS were also deconvoluted and three different
emitting species were observed for HMT AOT and HMT NTf2 as representative nanoGUMBOS
(Fig 5.7). The emission near 750 nm is assigned to the randomly oriented component. The two
emission peaks near 760 and 780 nm are probably due to the fluorescence of two different types
of J-aggregates that maybe formed within the nanoGUMBOS.

Figure 5.5. Normalized J/H ratio of the various HMT nanoGUMBOS
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Figure 5.6. Mole fraction of the randomnly oriented components of HMT nanoGUMBOS
A

B

Fig. 5.7. Representative resolved emission spectra of nanoGUMBOS (A) HMTAOT (B) HMT
NTf2
It is interesting to note that [HMT][AOT] and [HMT][3,5-(CF3)PhBF3] nanoGUMBOS
have comparable fluorescence to that of the corresponding dilute ethanolic GUMBOS solutions.
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The fluorescence of [HMT][NTF2] nanoparticles are slightly less than the corresponding
ethanolic solutions while that of [HMT][BETI] and [HMT][(OCH3(CF3)2)2Ph)4B] are highly
quenched compared to the corresponding ethanolic solution. This variation in fluorescence yield
of the nanoGUMBOS maybe explained by the type of preferred relative orientation of the
individual dye molecules in the nanoparticle. Consistent with this explanation, the more Jaggregating HMT nanoGUMBOS have greater fluorescence yield and the vice versa is true for
the predominantly H-aggregating nanoGUMBOS having the least fluorescence yield (Figures 5.4
and 5.5).
It can be inferred from these spectral properties that within the nanoGUMBOS of
HMTAOT, [HMT][NTF2] and [HMT][3,5-CF3PhBF3], head-to-tail type of arrangements are
thermodynamically more favored compared to stacking imparting highly fluorescent properties
to the nanoGUMBOS. In contrast, molecular stacking maybe more favored in [HMT][BETI] and
[HMT][(OCH3(CF3)2)2Ph4B], making these nanoGUMBOS weakly fluorescent to virtually nonfluorescent. It has been reported that cyanine dyes with longer polymethine chain are more Haggregating in solution. Despite having a long polymethine chain, the spectral properties of
HMT cationic cyanine dye used in this study suggest that J-aggregation likely occurs depending
on the anion used.
In general, solubility of ILs in water has been shown to be dependent on the anion.37
Hydrophobic anions such as BETI and NTF2 enhance the formation of hydrophobic GUMBOS.38
Generally, BETI has longer alkyl chain and more hydrophobic than NTF2- anion.38 We note that
the presence of fluorines have been reported to induce some hydrophilic properties.39 This
suggests that hydrophobicity may not be influenced solely by the length of the alkyl chain.
Therefore, in addition to structural factors which might determine the type of aggregation within
the nanoGUMBOS, the extent of hydrophobicities of the anions can be roughly correlated to the
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preferred orientation of the transition dipoles within the nanoparticles. The experimental results
from this study suggest that a higher degree of hydrophobicity of an anion within a given family
might induce a preferred stacking of the transition dipoles forming more H-type of aggregates.
5.3.5. Fluorescence Anisotropy Studies of HMT GUMBOS and NanoGUMBOS
In fluorescence anisotropy the rotational diffusion of a molecule is related to its size and
shape. It is a useful technique to measure the binding interaction between two molecules since
bound molecules rotate slowly resulting in higher anisotropy.40,

41

Fluorescence anisotropy is

calculated using the formula: r = (Ivv-GIvh)/(Ivv+2GIvh); where G is the grating factor that has
been included to correct the wavelength response for polarization response of the emission optic
and the detector. Ivv and Ivh are the fluorescence intensity measured parallel and perpendicular to
the vertically polarized excitation, respectively.40, 41
Fluorescence emission anisotropy studies were performed for both dilute HMT
GUMBOS ethanolic solutions as well as the nanoGUMBOS exciting at 737 nm. These
measurements reveal that the dilute ethanolic solutions of all the HMT GUMBOS have
significantly low anisotropies lying between 0.01-0.02 (Table 5.2). The anion has no significant
effect on the anisotropy in dilute solutions. All the HMT nanoGUMBOS possess higher
anisotropies than their corresponding dilute GUMBOS solutions (Table 5.2) and exhibit
fluorescence emission anisotropy spectra with different features for the different anions.
The [HMT][AOT] and [HMT][NTF2] which were found to be more J-aggregating
possess a low anisotropy value over the entire emission wavelength with an intense band near
775nm (Figure 5.8) which is approximately the absorption wavelength of the J-aggregates for
these nanoparticles as observed in the deconvoluted spectra. Thus it can be stated that the main
emitting species in these two cases are the J-aggregates having resonance fluorescence
properties. While for [HMT][3,5-(CF3)2PhBF3] the fluorescence anisotropy spectra exhibits a
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minima near 750 nm (Figure 5.8) revealing the fact that in this case the main emitting species is
the randomly oriented component which emits near the monomer region along with its Jaggregate which absorbs and emits near 754 nm as seen in the resolved spectra. As mentioned
earlier, J-aggregates are characterized by resonance fluorescence. But the value of anisotropy of
the particle is much greater than that of the corresponding monomer in dilute solutions
suggesting that the emitting species is within the particle and not in solution. This fact also
supports our deconvoluted data which shows maximum randomly oriented component for this
GUMBOS anion pair in which the J-aggregate absorbs near 754 nm. Fluorescence anisotropy
values of HMT BETI nanoparticles are much higher over the entire emission range with two
intense bands near 770 nm and 810 nm respectively (Figure 5.8) suggesting the presence of two
significantly different types of aggregates.
The fact that the fluorescence anisotropy of the dye aggregates in the nanoGUMBOS is
higher than the corresponding dilute dye solutions suggests that the rotational diffusion of the
dye within the nanoGUMBOS are much slower. Furthermore, negligible amount of energy is lost
through energy migration within the dye aggregates in the nanoGUMBOS. Another observation
that the NIR nanoGUMBOS with higher J/H ratio has lower values of emission anisotropy might
suggest that the rotational diffusion of the dye within the J-type of aggregates is faster compared
to that in randomly oriented or H-type of aggregates.
It is well established that anisotropy depends on the direction of transition moments.40, 41
In case of dye aggregates the transition dipoles are oriented in a definite manner and hence the
response to parallel and perpendicularly polarized light is quite distinct in the emission spectra. 40,
41

In this study, it was observed that a significant difference exists between the intensities of

perpendicular and parallel polarized emission for those HMT dye anion pairs in which the
transition dipoles are mostly oriented in head to tail manner i.e. forming J-type of aggregates. In
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addition, difference between the two emission intensities decreases with the decreasing Jcomponent. For example, [HMT][AOT] and [HMT][NTF2] has maximum difference between Ivv
and Ivh suggesting that these nanoGUMBOS contain maximum amount of J-aggregates (Figure
5.8). From the resolved absorption and emission spectra of [HMT] [3,5-(CF3)2PhBF3], the Jcomponent is comparatively lower. Consequently, the difference between Ivv and Ivh decreases
which is further diminished in predominantly H-aggregating HMT BETI nanoGUMBOS.
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Figure 5.8. Fluorescence emission anisotropy of (A) HMT AOT and (B) HMT NTF2
nanoGUMBOS (C) HMT 3, 5 (CF3)2 PheB (D) HMT BETI
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Table 5.2. Steady state anisotropy values of various HMT GUMBOS 1 µM ethanolic solution
and nanoGUMBOS aqueous suspension at 750 and 775 nm.

Abbreviation

Anisotropy
HMT GUMBOS 1 µM
HMT
nanoGUMBOS
ethanolic solution
aqueous suspension
750 nm

775 nm

750 nm

775 nm

HMT AOT

0.0215

0.02196

0.0435

0.0344

HMT35(CF3)PheB

0.01858

0.01904

0.08265

0.09846

HMT NTf2

0.01922

0.01723

0.04052

0.0365

HMT BETI

0.01103

0.01257

0.15809

0.14442

5.4. Conclusions
In summary, we have successfully presented a novel idea of controlling the type of
aggregation within the NIR nanoGUMBOS by retaining the same dye skeleton and simply
varying the anion. Though the various dye anion pairs have similar spectral properties in solution
phase, the nanoGUMBOS display intriguingly different properties as a function of varying the
anion. This tunable spectral behavior in the nanoGUMBOS is mainly attributed to the difference
in the arrangement of individual transition dipoles within the particles. The findings from this
study suggest that more hydrophobic anions may preferably induce H-aggregation in the
nanoGUMBOS. In contrast, J-aggregation may be preferred with less hydrophobic anions. It is
also possible that this observation may be dependent on the structure of the dye being
investigated.
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CHAPTER 6
CONCLUSIONS AND FUTURE DIRECTIONS

In addition to designing CILs for enantiomeric recognition, the work presented in this
dissertation is part of the effort to develop new nanomaterials from a new class of compounds
termed Group of Uniform Materials Based on Organic Salts (GUMBOS). The first part involves
the use of CILs that are liquid at room temperature (RTILs) for enantiomeric recognition of
various chiral analytes using fluorescence spectroscopy. The second part of this dissertation
mainly explores novel NIR fluorescent nanoGUMBOS as contrast agents for biomedical imaging
and investigates the tunability of the spectral properties of the nanoGUMBOS as a function of
varying the anion.
The first chapter provides a synopsis of the topics related to the work presented in this
dissertation such as ILs, CILs, chirality, NIR GUMBOS and nanoGUMBOS. The synthesis,
characterization and applications of CILs and nanoGUMBOS is described. In chapter 2, the
synthesis of a series of CILs in both enantiomeric forms form alanine tert-butyl ester chloride is
described. The alanine tert-butyl ester bis (trifluoromethane) sulfonylimide was obtained as
liquid at room temperature with high thermal stability. Both enantiomeric forms of alanine tertbutyl ester bis (trifluoromethane) sulfonylimide could be used as solvent and chiral selector for
enantiomeric recognition of various fluorescent analytes, alleviating the need for use of
environmentally damaging solvents to dissolve the analyte.
In Chapter 3, the work in chapter 2 is extended to include enantiomeric recognition of
analytes with reduced fluorescence by developing CILs from intrinsically fluorescent amino
acids. The synthesis, characterization and investigation of the enantiomeric recognition
properties of a fluorescent CIL, L-phenylalanine ethyl ester bis (trifluoromethane) sulfonimide
(L-PheC2NTf2) is reported for the first time. Such a CIL is advantageous over previously
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reported non-fluorescent CILs, whose applications were limited to the use of less sensitive
modes of detection such as absorption, or to the use of fluorescence in discrimination of a small
subset of intrinsically fluorescent analytes.
The results of an effort towards development of new nanomaterials in our research group
is presented in chapter 4 with the evaluation of novel NIR nanoGUMBOS derived form a
cationic NIR dye for biomedical imaging applications. It was also demonstrated that these NIR
fluorescent nanoGUMBOS could be efficiently taken up in vitro by Vero cells, suggesting an
interesting potential for non-invasive biomedical imaging applications. The nanoGUMBOS were
fabricated by use of a simple, rapid and additive-free reprecipitation method. Considering the
ease of preparation, this work presents an entirely new direction for preparing contrast agent
nanoGUMBOS directly from tailored ionic materials. The approach described alleviates current
problems associated with dye leakage and other challenges encountered in dye encapsulation, as
well as obviating intensive purification steps required when surfactants are used to prepare dye
nanoparticles. We note that the spectral properties of our GUMBOS were strikingly different
from the freely dissolved dye present in solution. Thus, the possibility for tuning the optical
properties of GUMBOS by variation in the parent ions offers a unique and exciting advantage for
these nanomaterials. Since the NIR fluorescent nanoGUMBOS could be efficiently taken up in
vitro by Vero cells, the prospect of tailoring nanoGUMBOS for delivery into designated cellular
structures is an exciting new research possibility. In addition, this work could easily be extended
to include GUMBOS with more than one property. For instance, incorporating a magnetic anion
with the NIR nanoGUMBOS provides fluorescent and magnetic bimodal imaging modes.
Chapter 5 seeks answers to the intriguing observations made on the spectral properties of
the NIR nanoGUMBOS upon variation of the anion. These NIR nanoGUMBOS described in
chapter 4 displayed broad absorption spectra and the fluorescence emission of the
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nanoGUMBOS was blue shifted compared to the dilute solution of the monomeric dye. These
observations have been previously attributed to molecular aggregation and efforts to explain and
control this phenomenon are detailed in the dissertation. The findings from this study suggest
that both H and J aggregation occur at relatively different proportions depending on the anion.
As far as is known, the most interesting part of our study is the unprecedented possibility of
controlling the type of aggregation within the NIR nanoGUMBOS by retaining the same dye
cationic skeleton and simply varying the counterion. In future, the possibility of preparing NIR
nanoGUMBOS system containing both H and J aggregates exhibiting superradiance (a
phenomena resulting from cooperative emission) will be of tremendous interest. In addition to
varying the anion, the design of cation/ anion combination or conditions that can exclusively
achieve the desired aggregate (H or J) for specific applications will be a useful study. Further, it
is interesting that J aggregates derived from non-chiral molecules have been noted to be CD
active due to the helical arrangement of J aggregates. This is another possible investigation on
the NIR nanoGUMBOS to distinguish the various aggregates since the H aggregates and
monomers do not exhibit this chiral activity.
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